HoldsUp

Huberman Lab · 2026-03-23 · Andrew Huberman (host), Rhonda Patrick

The Best Vitality & Health Protocols | Dr. Rhonda Patrick

127 research-tied claims examined: 2 contradicted 15 overstated 9 context 94 supported 7 unverified

2 Contradicted by research
0:46:15Rhonda Patrickcontradictedmoderate

When LPS binds to the apoB protein on small dense LDL particles, hepatic LDL receptor recognition is obscured, preventing normal liver clearance and causing arterial wall entrapment and foam cell formation by macrophages.

"And so when it's time to get recycled back into the liver, what do you know? The apoB protein's obscured by that LPS and it's not recycled. And so it gets lodged into the arterial wall. And because there's an LPS bound to this small dense LDL particle, macrophages... tries to engulf it, but it can't cuz it's not bacteria, and you get the macrophage stuck to that lipoprotein-LPS complex and you get the formation of a foam cell." (said at 0:46:15)

The speaker's proposed mechanism is contradicted by physiological and mechanistic evidence on lipoprotein-endotoxin clearance and foam cell biology. First, pathogen lipids like lipopolysaccharide (LPS) transferred to apoB-containing lipoproteins (including LDL) do not obscure hepatic receptor recognition to block clearance; rather, the LDL receptor (LDLR) pathway is a primary physiological mechanism by which circulating LPS bound to apoB lipoproteins is cleared by hepatocytes and excreted into bile. Second, macrophage foam cell formation does not occur because macrophages fail to engulf LDL particles and get 'stuck'; rather, macrophages actively internalize modified lipoproteins (such as oxidized LDL) via scavenger receptors (e.g., CD36, SR-A) faster than cholesterol can be effluxed, accumulating intracellular lipid droplets to become foam cells.

1:05:48Rhonda Patrickcontradictedlow

Chronic negative stress increases glucocorticoid receptor density and decreases mineralocorticoid receptor density, unlike hormetic stressors.

"So, if you if you look at what activates cortisol in a negative way: chronic stress, let's say emotional, financial, psychological; chronic sleep deprivation; like that bad type of stress, you're not getting a big spike, you're getting a slow drip of it. And so, what happens is when you have that type of stress, you're increasing the glucocorticoid receptors, and you're decreasing the mineralocorticoid receptors." (said at 1:05:48)

The speaker claims that chronic negative stress increases glucocorticoid receptors (GRs) and decreases mineralocorticoid receptors (MRs). The direction of effect for glucocorticoid receptors is inverted: extensive neurobiological research shows that chronic stress and prolonged glucocorticoid elevation downregulate or desensitize glucocorticoid receptors (GRs) in key brain regions like the hippocampus and prefrontal cortex, impairing negative feedback regulation of the hypothalamic-pituitary-adrenal (HPA) axis. While chronic stress does downregulate MRs (as stated in the second part of the claim), asserting that chronic negative stress increases GR density contradicts established findings.

15 Overstated
0:11:59Rhonda Patrickoverstatedlow

As little as 10 minutes of vigorous-intensity exercise immediately increases neuronal connectivity and improves executive function by approximately 14%, translating to about a 50-millisecond improvement in processing speed.

"there's been studies showing that you have an improvement in executive function by like 14%, which is pretty big. I think it was like a 50-millisecond improvement processing speed or something which doesn't sound a lot, but actually translates to a big improvement in executive function." (said at 0:11:59)

The speaker appears to refer to acute exercise trials such as Samani & Heath (2018; PMID: 29191783), which evaluated executive control using an antisaccade oculomotor task before and after a 10-minute bout of moderate-to-vigorous cycling in healthy young adults. The study found a statistically significant ~27-millisecond reduction in reaction time (an improvement of roughly 10–14%), rather than a 50-millisecond change. While the general direction and approximate percentage match published laboratory findings, generalizing transient reductions in saccadic reaction time in a small sample to broad, lasting improvements in processing speed and executive function is overstated.

0:24:36Andrew Huberman (host)overstatedlow

The anterior midcingulate cortex is hyperplastic throughout the lifespan and enlarges when individuals perform tasks they find effortful and dislike doing.

"the anterior midcingulate cortex is the brain area that is hyperplastic throughout the lifespan, which is rare for a brain area, and it enlarges um when we do things we don't want to do. It's not just about doing hard things. It's about It's about doing the hard thing you hate." (said at 0:24:36)

The anterior midcingulate cortex (aMCC) is widely described in neuroimaging and cognitive neuroscience literature as a critical structural and functional hub for tenacity, cognitive control, allostatic energy regulation, and persistence in the face of challenge (Touroutoglou et al., 2020; Touroutoglou et al., 2019). However, the specific claim that the aMCC is uniquely 'hyperplastic throughout the lifespan' and that it directly 'enlarges' when individuals perform tasks they subjectively dislike or 'hate' takes conceptual models of effort valuation and cross-sectional neuroimaging findings and overstates them as established anatomical growth mechanisms.

0:51:22Rhonda Patrickoverstatedlow

Studies show that high-dose glutamine supplementation (approximately 30 g) reduces the incidence of respiratory tract infections in endurance athletes.

"there's a few studies out there showing that if these athletes take a higher dose of glutamine—I think it's like 30 g or something high like that—that they had a lower incidence of respiratory tract infections than the ones that weren't doing it." (said at 0:51:22)

While early small studies by Castell et al. (1996, 1997) reported that post-exercise oral glutamine supplementation (typically two 5 g doses, totaling 10 g, rather than 30 g) significantly reduced the incidence of self-reported upper respiratory tract infections in endurance runners and rowers, subsequent systematic reviews and broader evidence syntheses have found that glutamine does not reliably alter immune parameters or prevent upper respiratory tract infections in athletes.

0:55:10Andrew Huberman (host)overstatedmoderate

A clinical study showed that N-acetylcysteine (NAC) supplementation significantly reduced the rate of contracting influenza upon exposure compared to placebo, dropping infection from the high 70% range to around the high 20% range.

"There's at least one study showing that it reduced flu transmission where people were deliberately exposed to flu. I think it took the number of people that contracted flu compared to the placebo group somewhere from the high 70% area—I don't remember the exact number now, we'll put a link to the study—down to maybe high 20s, which is pretty impressive." (said at 0:55:10)

The speaker refers to a well-known 1997 randomized, double-blind, placebo-controlled trial by De Flora et al. (PMID: 9230243) evaluating 6 months of oral NAC (600 mg twice daily) in 262 individuals. However, the speaker misrepresents two key aspects of the study. First, it was not a human challenge study with deliberate viral exposure, but an evaluation during natural winter exposure in community-dwelling older adults (78% aged ≥65). Second, NAC did not reduce the rate of contracting the virus (influenza transmission/seroconversion rates were similar between groups). Rather, among individuals who became infected (seroconverted to A/H1N1), only 25% developed symptomatic influenza-like illness in the NAC group compared to 79% in the placebo group.

1:03:24Rhonda Patrickoverstatedlow

Studies by Satchin Panda show that stopping eating three hours before bed improves sleep.

"I know Satchin Panda, he's been on my podcast, your podcast. He's had studies showing that it seemed like stop stop eating 3 hours before bed really does seem to improve sleep." (said at 1:03:24)

Dr. Satchin Panda's research group has investigated time-restricted eating (TRE) and circadian meal timing, frequently recommending that individuals finish eating 2 to 4 hours before sleep to support circadian alignment. However, claiming his studies demonstrated that stopping eating 3 hours before bed definitively improves sleep overstates the findings. In human clinical pilot studies co-authored by Panda evaluating TRE (such as 8-to-10-hour eating windows that reduce late-night eating), primary objective sleep metrics (e.g., actigraphy) generally did not show significant improvements from baseline, although greater eating window restriction was associated with longer sleep duration and participants subjectively reported improved sleep quality. The available clinical evidence from these trials is preliminary, consisting of small pilot samples.

1:09:13Andrew Huberman (host)overstatedlow

Scientific evidence shows that deliberate cold exposure increases adrenaline and peripheral dopamine while lowering cortisol.

"there's also this idea that deliberate cold exposure increases cortisol, but when you look at the data, it definitely increases adrenaline and peripheral dopamine and probably—I'll go on record, probably central dopamine, although we don't have as good evidence for that yet. But the evidence points to the fact that deliberate cold exposure lowers cortisol." (said at 1:09:13)

The claim overstates and partially conflates the hormonal effects of cold exposure. In the landmark human trial examining this (Šrámek et al., 2000, n=10), 1-hour immersion in 14°C cold water caused large increases in plasma noradrenaline (530%) and dopamine (250%), but plasma adrenaline (epinephrine) concentrations remained unchanged. Furthermore, while cortisol did not increase and tended to decline slightly during immersion in that trial (a phenomenon largely attributed to hydrostatic pressure and circadian drift rather than cold per se), other cold-exposure studies show cortisol either remains unchanged or increases depending on the severity of the cold, shivering, and exercise conditions.

1:13:08Rhonda Patrickoverstatedlow

High levels of visceral fat are associated with double the risk of early death.

"It's associated with double the increased risk double the risk of early death." (said at 1:13:08)

While elevated visceral adipose tissue (VAT) is associated with an increased risk of all-cause mortality, stating that it doubles the risk is an overstatement. In a large systematic review and dose-response meta-analysis (PMID 35717418), each 1-SD increment in VAT was associated with a 17% increase in all-cause mortality (HR 1.17, 95% CI: 1.03–1.33). Another systematic review (PMID 36082075) observed an 11% to 98% relative risk increase across cohorts of adults aged ≤65 years, but noted that the association frequently lost statistical significance after adjusting for BMI and glycemic parameters and was inconsistent in adults over 65 years. The evidence is derived from observational cohorts prone to residual confounding.

1:14:47Rhonda Patrickoverstatedmoderate

Unlike subcutaneous fat, visceral fat lipolysis does not shut down in response to insulin, continually releasing free fatty acids to the liver via the portal vein.

"Visceral fat is very different from subcutaneous fat because it doesn't respond to insulin like subcutaneous fat does. In other words, when you have a meal, you eat a carbohydrate meal, and basically your body increases insulin to help take up glucose into your liver, muscle, adipose tissue, lipolysis shuts down, right? So, "Okay, no longer am I going to break down these fats, it's time to use this energy," right? Visceral fat doesn't respond to insulin, so it just keeps going, right?" (said at 1:14:47)

The speaker overstates a relative physiological difference as an absolute one. Visceral (omental) adipose tissue is significantly less sensitive to the antilipolytic actions of insulin compared to subcutaneous adipose tissue, leading to a higher rate of lipolysis and free fatty acid flux to the liver via the portal vein. However, visceral fat is not completely unresponsive to insulin; rather, it exhibits lower insulin sensitivity and higher catecholamine responsiveness compared to subcutaneous depots.

1:32:22Rhonda Patrickoverstatedlow

A recent study by Mark Mattson found that a 5:2 intermittent fasting protocol (restricting calories to ~500 on 2 days per week) resulted in a 20% improvement across a battery of cognitive tests compared to a standard calorie-restricted healthy diet.

"Mark Mattson just published a study very very recently showing that he did a I think he was doing a 5:2 intermittent fasting protocol where it's like 2 days you're getting pretty severe caloric restriction. Like you're eating one meal, but it's like 500 calories, you know, for that for the day. And it's twice 2 days 2 days out of the week. The other 5 days you're eating normal and compared that to calorie like eating eating like a healthy diet and they were somewhat calorie restricted but not quite as much as the people that were doing the fasting and they had the fasting group had massive cognitive benefits like 20% improvement in a battery of tests that were done." (said at 1:32:22)

A 2024 randomized controlled trial co-authored by Mark Mattson (PMID 38901423) tested an 8-week 5:2 intermittent fasting protocol against a healthy living diet in 40 older adults with insulin resistance. The trial found that both diets improved executive function and memory, with 5:2 intermittent fasting benefiting certain cognitive sub-measures more than the healthy living diet. However, describing this as a 'massive cognitive benefit' or a uniform '20% improvement across a battery of cognitive tests' overstates the findings of this small pilot trial (n=40), where both dietary interventions showed comparable improvements across multiple neurobiological and cognitive endpoints.

1:49:23Rhonda Patrickoverstatedmoderate

Performing 10 bodyweight squats every 45 minutes across a 7.5-hour workday is more effective at regulating blood glucose levels than a single continuous 30-minute walk.

"showing that getting up and doing 10 bodyweight squats every 45 minutes over a 7 and 1/2 hour work day is better at regulating blood glucose levels than a 30-minute walk, right?" (said at 1:49:23)

Studies evaluating interrupted sitting across laboratory-based workday models (typically 7.5 to 8 hours) show that frequent bodyweight resistance breaks (such as 10–15 chair stands or squats every 20–30 minutes) reduce postprandial insulinemia and, in individuals with type 2 diabetes, glucose excursions compared to continuous uninterrupted sitting. However, trials comparing intermittent bodyweight squats specifically to a continuous 30-minute walk across a 7.5-hour day do not demonstrate superior blood glucose regulation for squats; in healthy adults, 15 chair stands every 30 minutes reduced postprandial insulin area under the curve compared with prolonged sitting without significantly altering plasma glucose concentrations.

2:14:33Rhonda Patrickoverstatedvery low

Studies show that giving approximately 20 grams of creatine to older adults with mild cognitive impairment or early-stage Alzheimer's disease improves cognitive function.

"There've been studies coming out since then showing that, okay, if you give older adults with mild cognitive impairment, perhaps mild, you know, early stage Alzheimer's disease, again, 20 grams, you're giving them in the 20 g range of creatine, it's improving their cognitive function." (said at 2:14:33)

The speaker's claim refers to findings from an early pilot study testing ~20 g/day of creatine monohydrate in Alzheimer's disease, but overstates the strength of the evidence. Specifically, the only clinical study evaluating 20 g/day in AD patients (the CABA pilot trial, n=20) was a small, single-arm feasibility pilot without a placebo control group. While participants showed statistically significant improvements on certain cognitive composites and tests over 8 weeks, the lack of a control group means re-test/practice effects cannot be ruled out, and definitive efficacy has not yet been demonstrated in randomized controlled trials.

2:22:30Rhonda Patrickoverstatedlow

A high omega-3 index is associated with a 5-year increased life expectancy and a 90% reduction in sudden cardiac death.

"5-year increased life expectancy if you're on the high end. Um you're talking about 90% reduction in sudden cardiac death." (said at 2:22:30)

The speaker's figures refer to observational cohort findings rather than established clinical trial outcomes. The ~5-year difference in life expectancy is derived from statistical modeling of the Framingham Offspring Cohort (PMID: 34134132, PMID: 29559306), where individuals in the highest quintile of the Omega-3 Index had a 34% lower risk of all-cause mortality compared to the lowest quintile (an effect size comparable to roughly 4.7-5 years of life expectancy or the gap between smokers and non-smokers). Similarly, the ~90% reduction in sudden cardiac death refers to observational cohort analyses comparing extreme quantiles of baseline blood omega-3 levels (e.g., the Physicians' Health Study), whereas pooled meta-analyses of prospective cohorts and trials indicate a more modest ~15% to 30% reduction in fatal coronary events (PMID: 28511049). Presenting these observational associations as direct life expectancy gains and 90% risk reductions overstates the evidence.

2:27:54Rhonda Patrickoverstatedmoderate

In a clinical trial (the DO-HEALTH trial), omega-3 supplementation alone reduced the rate of pre-frailty by approximately 16%.

"three months slowing the epigenetic aging clock by omega-3 only is going to get you like, you know, 16% lower pre-frailty... And then the pre-frailty was the omega-3 alone" (said at 2:27:54)

In the DO-HEALTH randomized clinical trial (Bischoff-Ferrari et al., 2023), omega-3 supplementation alone did not produce a statistically significant reduction in the odds of incident pre-frailty over 3 years. The authors reported that 'Odds ratios for becoming pre-frail were not significantly lower for vitamin D3, or omega 3-s, or SHEP, individually, compared to control', whereas only the combination of all three treatments (vitamin D3, omega-3, and exercise) achieved a statistically significant reduction (OR 0.61, p=0.04). While exploratory point estimates for omega-3 alone may have hovered around an OR of 0.84 (~16% lower odds), presenting this as a proven reduction from omega-3 alone overstates a non-significant result.

3:07:21Rhonda Patrickoverstatedvery low

Nicotinamide riboside (NR) is involved in improving fertility, sperm health, and egg health by improving mitochondrial health.

"If you can improve mitochondrial health, fertility, which is why NR is now involved with fertility. It seems to be improving fertility. It's right. If you can improve mitochondrial health, then you're going to improve fertility, sperm health, right? Egg health, right?" (said at 3:07:21)

Preclinical animal and in vitro models demonstrate that nicotinamide riboside (NR) supplementation boosts cellular NAD+ levels, enhances mitochondrial function, reduces oxidative stress, and improves oocyte (egg) quality, live birth rates, and sperm parameters in aged, diabetic, or genetically impaired rodents and boars. However, stating definitively that NR improves human fertility, sperm health, and egg health overstates the evidence, as robust randomized controlled trials in humans are lacking.

3:23:24Rhonda Patrickoverstatedlow

Literature shows that creatine supplementation in young children participating in sports like soccer improves agility and is safe.

"Yeah, so there is data in the literature showing that if you give younger younger children that are doing like, for example, sports like soccer, it does seem to improve their agility. And it seems to be safe." (said at 3:23:24)

While some literature reviews of adolescent athletes note a general lack of adverse events and potential performance benefits, the evidence specifically supporting agility improvements and safety in young children is weak and inconsistent. A meta-analysis of soccer players (PMID 30935142) found that creatine supplementation did not significantly improve phosphagen-system performance tests, which included agility (p = 0.08). Furthermore, a systematic review of pediatric and adolescent athletes (PMID 37008451) concluded that the overall quality of studies is poor, there are no consistent performance benefits, and no studies have been designed to properly evaluate safety.

9 Needs context
0:14:41Andrew Huberman (host)needs contextlow

PFAS (per- and polyfluoroalkyl substances) are found in approximately 80% of nonstick pans as well as other kitchen products.

"Surprisingly, toxic compounds such as PFASes, or forever chemicals, are still found in 80% of nonstick pans, as well as utensils, appliances, and countless other kitchen products." (said at 0:14:41)

Per- and polyfluoroalkyl substances (PFAS), particularly the fluoropolymer polytetrafluoroethylene (PTFE, commonly known as Teflon), constitute the predominant coating technology used in traditional nonstick cookware, utensils, and food contact materials. Systematic reviews of consumer products and human biomonitoring identify nonstick cookware as a recognized source and correlate of PFAS exposure. However, the precise statistic that PFAS are present in exactly '80%' of nonstick pans derives from commercial market-share estimates and consumer advocacy testing rather than standardized epidemiological or toxicological benchmarks. Additionally, while legacy PFAS such as PFOA have been largely phased out of manufacturing processes, fluoropolymer coatings (which fall under broad definitions of PFAS) remain widely used.

0:37:25Rhonda Patrickneeds contextmoderate

In celiac disease, gluten exposure causes intestinal tight junctions to open and stay open, leading to large-scale LPS leakage into circulation.

"the I would say the opposite end of the spectrum of that would be like celiac where they eat gluten or something, it opens up and stays open and so you get like a ton of LPS leakage into the system which causes massive inflammation." (said at 0:37:25)

The speaker correctly identifies that in celiac disease, gluten/gliadin exposure triggers zonulin release, tight junction disassembly, and increased intestinal epithelial permeability. However, describing the resulting inflammation as primarily driven by 'a ton of LPS leakage into the system' mischaracterizes celiac pathophysiology. While barrier dysfunction does permit increased translocation of luminal antigens (including microbial components like LPS), the primary driver of mucosal and systemic inflammation in celiac disease is a specific adaptive and innate immune response to deamidated gliadin peptides presented by HLA-DQ2 or HLA-DQ8 molecules, rather than generalized systemic lipopolysaccharide endotoxemia.

0:47:42Andrew Huberman (host)needs contextvery low

Experimental injection of lipopolysaccharide (LPS) into the gut induces a fever response that is abolished if the vagus nerve is transected.

"LPS injected into the gut is how you actually experimentally induce a fever because and if you cut the vagus, no fever." (said at 0:47:42)

The host is describing animal experiments in neuroimmunology investigating abdominal immune-to-brain signaling. In rodents, subdiaphragmatic vagotomy abolishes or attenuates the early or low-dose febrile response to intraperitoneal or intravenous LPS. However, vagotomy does not completely eliminate fever at moderate to high doses of LPS, where humorally mediated pathways (circulating pyrogenic cytokines acting on the brain) induce fever independently of the vagus nerve.

1:13:13Rhonda Patrickneeds contextlow

People with high visceral fat have a 44% higher chance of developing cancer.

"Um, people that have high visceral fat have 44% higher chance of having cancer, many different types of cancers." (said at 1:13:13)

Epidemiological and prospective cohort studies consistently show that elevated visceral adipose tissue (or indices of visceral adiposity such as the visceral adiposity index) is associated with an increased risk of several obesity-related cancers, particularly gastrointestinal, colorectal, and endometrial malignancies, with relative risk elevations often ranging between 20% and 50% (e.g., hazard ratios around 1.20 to 1.50). However, the claim's precise figure of a '44% higher chance' across 'many different types of cancers' generalizes a specific risk estimate to cancer broadly, whereas visceral adiposity risk varies widely by specific cancer site, sex, and measurement method.

1:31:12Rhonda Patrickneeds contextlow

Beta-hydroxybutyrate increases GABA and balances glutamate and GABA neurotransmission in the brain.

"the ketones like beta-hydroxybutyrate are increasing GABA. They're like balancing the glutamate, the you know, excitatory neurotransmitter with the inhibitory one, GABA." (said at 1:31:12)

The idea that beta-hydroxybutyrate (BHB) increases GABA and balances glutamate-GABA neurotransmission originates from preclinical and ketogenic diet models, where chronic ketosis is associated with increased GABA synthesis (via upregulation of glutamic acid decarboxylase) and altered glutamate transamination. However, direct in vivo human studies using proton magnetic resonance spectroscopy (MRS) show complex and contrasting results. In healthy adults, acute administration of a BHB ketone ester significantly decreased both GABA and glutamate concentrations in the anterior and posterior cingulate cortices, while another acute human study observed an increase in occipital glutamate without a change in GABA. Thus, while BHB modulates excitatory and inhibitory neurotransmitter systems, it does not universally increase brain GABA levels.

1:48:34Rhonda Patrickneeds contextlow

Engaging in 3 minutes of vigorous intermittent lifestyle physical activity (VILPA) three times a day (totaling 9 minutes daily) is associated with a 40% reduction in all-cause mortality, a 40% reduction in cancer mortality, and a 50% reduction in cardiovascular mortality.

"individuals that do on the high end, so they're doing, you know, 3 minutes of this short burst of an unstructured type of exercise snack and they do it three times a day. So, it's a total of 9 minutes a day. Okay, this type of activity, and it's considered more vigorous because you're the intent to move, right? That's more vigorous even though they're not measuring heart rate. That's associated with a 40% reduction in all-cause mortality, 40% reduction in cancer-related mortality, a 50% reduction in cardiovascular-related mortality." (said at 1:48:34)

The speaker accurately cites the findings from a landmark UK Biobank prospective cohort study by Stamatakis et al. (2022), but slightly misstates the bout length and total daily duration. The study found that engaging in 3 bouts of VILPA per day (lasting 1 or 2 minutes each, amounting to a median of ~3 to 4.4 minutes daily, not 3 minutes per bout or 9 minutes total) was associated with a 38%-40% reduction in all-cause and cancer mortality risk and a 48%-49% reduction in CVD mortality risk compared to no VILPA. As this is an observational cohort study, certainty is graded as low.

1:50:10Rhonda Patrickneeds contexthigh

Current physical activity guidelines recommend 150 minutes of moderate-intensity exercise and 75 minutes of vigorous-intensity exercise per week.

"physical activity guidelines right now, which is 75 minutes of vigorous intensity exercise and 150 minutes a week of moderate intensity exercise." (said at 1:50:10)

Major public health guidelines—including those from the World Health Organization (WHO) and the US Department of Health and Human Services—recommend 150–300 minutes of moderate-intensity aerobic physical activity OR 75–150 minutes of vigorous-intensity physical activity per week, or an equivalent combination thereof. The speaker's statement frames the standard minimum thresholds (150 minutes of moderate and 75 minutes of vigorous exercise) with 'and' rather than 'or', which could erroneously imply that both quantities must be completed concurrently.

2:56:53Rhonda Patrickneeds contextmoderate

Synthetic clothing is the primary source of microplastics entering the ocean.

"It's the main source of microplastics in the ocean, right? Because they're washed We're washing our clothes, and there's They're every this cute shirt that I'm wearing, I mean, it's it's got microplastics in it for sure. Um and and so every time you're washing your clothes, your all the microplastics are coming out and and getting into the ocean." (said at 2:56:53)

Synthetic textiles (shedding microfibers during laundering) are widely recognized as the single largest contributor to *primary* microplastics entering marine environments (estimated to account for approximately 35% of primary microplastic emissions globally). However, the claim requires qualification: primary microplastics represent only a fraction of total marine microplastics. The majority of all microplastics in the ocean are *secondary* microplastics resulting from the gradual fragmentation and degradation of larger mismanaged macroplastics (such as plastic bags, bottles, packaging, and fishing gear).

3:12:58Rhonda Patrickneeds contextlow

Beta-hydroxybutyrate increases GABA levels.

"it's because it increases GABA. The beta-hydroxybutyrate increases GABA." (said at 3:12:58)

The claim that beta-hydroxybutyrate (BHB) increases GABA levels is a longstanding hypothesis derived primarily from preclinical and in vitro studies (e.g., in rat brain synaptosomes and astrocyte cultures, where BHB increased GABA synthesis or inhibited its degradation). However, human in vivo evidence complicates this: ultrahigh-field (7T) proton magnetic resonance spectroscopy (MRS) in healthy adults demonstrated that acute administration of D-BHB actually significantly reduced cortical GABA and glutamate levels in the anterior and posterior cingulate cortices, and another human MRS study showed no increase in occipital GABA.

94 Supported by research
0:00:00Rhonda Patricksupportedlow

Performing unstructured 3-minute bursts of vigorous physical activity three times a day (a total of 9 minutes daily) is associated with a 40% reduction in all-cause mortality, a 40% reduction in cancer-related mortality, and a 50% reduction in cardiovascular disease mortality.

"So, for example, individuals that do on the high end, so they're doing, you know, 3 minutes of this short burst of an unstructured type of exercise snack, and they do it three times a day. So, it's a total of 9 minutes a day. Okay? That's associated with a 40% reduction in all-cause mortality, 40% reduction in cancer-related mortality, a 50% reduction in cardiovascular-related mortality." (said at 0:00:00)

The claim accurately reflects findings from a landmark UK Biobank prospective cohort study of 25,241 non-exercisers published by Stamatakis et al. (Nature Medicine, 2022). The study found that engaging in a median of 3 daily bouts of vigorous intermittent lifestyle physical activity (VILPA, standardized to 1 or 2 minutes per bout) was associated with a 38% to 40% reduction in all-cause and cancer mortality risk, and a 48% to 49% reduction in cardiovascular disease (CVD) mortality risk compared to individuals with no VILPA. While the speaker described bouts of 3 minutes (totaling 9 minutes daily), the actual study observed these risk reductions at even shorter bout durations (1 to 2 minutes each, totaling 3 to 4.4 minutes daily). As an observational cohort study, the certainty of evidence is low due to potential residual confounding and reverse causation.

0:13:20Rhonda Patricksupportedmoderate

High-intensity exercise significantly increases plasma serotonin levels compared to lower-intensity exercise, which correlates with improved impulse control.

"And it was the high intensity, you know, vigorous intensity exercise that really increased plasma serotonin, which has been shown to associate with brain serotonin. The studies have been done. And serotonin is very important for, as you know, for impulse control. ... And so the studies showed that plasma serotonin increased in the higher intensity group and that correlated with improved impulse control." (said at 0:13:20)

A randomized controlled trial by Zimmer et al. (2016) in 121 young adults directly tested this question across low (45% HRmax), moderate (65% HRmax), and high-intensity (85% HRmax) exercise groups versus a control. The researchers found that high-intensity exercise significantly increased peripheral (serum) serotonin levels compared to controls, with a significant linear relationship between exercise intensity and serotonin increases. Furthermore, increased serotonin concentrations significantly correlated with improvements in response inhibition (impulse control assessed via the Stroop task). Note that the study measured serum rather than plasma serotonin, but peripheral blood serotonin changes and cognitive associations precisely matched the speaker's description.

0:14:50Andrew Huberman (host)supportedmoderate

Per- and polyfluoroalkyl substances (PFAS) are linked to endocrine disruption, gut microbiome disruption, and fertility issues.

"these PFASes, or forever chemicals like Teflon, have been linked to major health issues such as hormone disruption, gut microbiome disruption, fertility issues, and many other health problems." (said at 0:14:50)

Scientific literature robustly links exposure to per- and polyfluoroalkyl substances (PFAS) to endocrine (hormone) disruption, impaired fertility, and alterations in the gut microbiome. Comprehensive reviews and epidemiological studies confirm associations between PFAS exposure and thyroid/gonadal hormone imbalances, adverse reproductive outcomes (such as impaired gamete viability, menstrual irregularity, and reduced fecundity), and gut dysbiosis/altered microbial metabolism.

0:16:24Andrew Huberman (host)supportedhigh

The CDC estimates that more than 1 in 3 American adults has prediabetes, and many individuals do not know they have it.

"The CDC estimates that more than one in three American adults has prediabetes and that many of these people don't know they are living with prediabetes." (said at 0:16:24)

The CDC's national surveillance estimates (based on NHANES data) consistently show that more than 1 in 3 US adults (approximately 38%, or roughly 96 million adults in recent estimates) have prediabetes, and the vast majority (around 80-90%, with awareness historically measured between ~7% and ~14%) are unaware that they have the condition.

0:25:29Andrew Huberman (host)supportedlow

Anterior midcingulate cortex volume is the strongest anatomical brain correlate observed in superagers.

"And that's actually the thing in these so-called super agers that is the strongest anatomical correlate that we have." (said at 0:25:29)

Neuroimaging and postmortem studies of 'SuperAgers' (older adults aged 80+ with episodic memory performance comparable to individuals decades younger) consistently identify the anterior cingulate cortex (ACC) and anterior midcingulate cortex (aMCC) as a primary neuroanatomical correlate. Superagers show preserved or thicker cortical grey matter in the ACC/aMCC compared with cognitively average peers and middle-aged adults, along with higher densities of von Economo neurons. The body of evidence consists of small observational cohort studies.

0:35:07Rhonda Patricksupportedmoderate

Ultra-processed carbohydrates and additives increase gut permeability, allowing lipopolysaccharide (LPS) to enter the bloodstream and trigger an immune response.

"It's the more processed types of carbohydrates that as you mentioned, it's like typically you don't feel good after you eat them. And you know, part of that's the postprandial inflammatory response cuz some of those foods are a little more inflammatory. I mean, a lot of additives and stuff that are affecting the gut, gut permeabilization, you're leaking lipopolysaccharide into the bloodstream, right? That's activating the immune system." (said at 0:35:07)

The speaker's statement accurately summarizes the established biological mechanism of metabolic endotoxemia: refined/high-carbohydrate diets and specific food additives (such as dietary emulsifiers) can disrupt the gut microbiota and compromise the intestinal epithelial barrier (gut permeability), permitting the translocation of bacterial lipopolysaccharide (LPS) into systemic circulation, which in turn stimulates innate immune receptors and drives systemic inflammation.

0:36:56Rhonda Patricksupportedmoderate

The human gut contains approximately one gram of lipopolysaccharide (LPS) on average.

"So we have about a gram of LPS in our gut. Like that's on average cuz you know, lipopolysaccharide is the outer component of a cell membrane of gram-negative bacteria, right?" (said at 0:36:56)

Published microbiological and immunological literature supports the claim that the human gastrointestinal tract harbors an estimated 1 gram (or exceeding 1 gram) of lipopolysaccharide (LPS/endotoxin), derived from the outer membranes of the dense resident Gram-negative bacterial community.

0:37:08Rhonda Patricksupportedmoderate

Intestinal epithelial tight junctions transiently open and close during normal meal consumption.

"So when we eat food, typically like our gut epithelial cells have a tight junction that's holding them together. When we eat food, they transiently open and then close. Like it's kind of a normal response, right?" (said at 0:37:08)

During meal consumption and nutrient absorption (such as glucose uptake via the sodium-glucose cotransporter SGLT1), intestinal epithelial tight junctions undergo physiological, reversible regulation. Nutrient transport triggers myosin light-chain kinase (MLCK) activation and actomyosin contraction, which transiently increases tight junction permeability (lowers transepithelial electrical resistance) to allow paracellular flux of small solutes and water, returning to baseline once luminal nutrients are cleared.

0:37:45Rhonda Patricksupportedmoderate

Consuming refined sugars combined with saturated fats induces a postprandial LPS response and gut inflammation.

"So, when I say refined carbohydrates, it's not necessarily like healthy carbohydrates like vegetables. It's like you're eating something that is refined sugar typically with saturated fat. So, those types of foods really cause like LPS response. You know, it's inflammation. It's hard on the gut." (said at 0:37:45)

Human clinical feeding studies show that consuming a high-fat, high-carbohydrate meal (typically containing saturated fats and refined sugars/carbohydrates) induces acute postprandial metabolic endotoxemia (increased plasma lipopolysaccharide [LPS] concentrations) along with activation of inflammatory pathways (such as NF-kB binding, TLR2/4 expression, and reactive oxygen species generation). In contrast, meals high in fiber and fruit do not induce this response.

0:41:15Rhonda Patricksupportedhigh

A clinical study demonstrated that individuals self-identifying as gluten sensitive experienced severe abdominal bloating and symptoms when fed gluten-free bread they believed contained gluten (a nocebo effect).

"Have you seen that study where people There were people that think they're gluten sensitive and so they were enrolled in a study and these individuals were separated into two groups. One group was given the bread with gluten and the other group was given the bread without gluten, and the people that were given the bread without gluten had a terrible abdominal res— like they were bloated, they felt terrible. And there was no gluten in the actual bread, but they thought there was." (said at 0:41:15)

Double-blind, placebo-controlled crossover trials in individuals with self-reported non-celiac gluten sensitivity (notably Biesiekierski et al., 2013) have demonstrated a prominent nocebo effect. When participants were challenged with gluten-free control diets (or whey protein placebo), their gastrointestinal symptoms—including bloating, pain, and abdominal distress—worsened to the same degree as when receiving gluten, demonstrating that expectation bias and nocebo mechanisms significantly drive symptoms in this population.

0:42:15Rhonda Patricksupportedhigh

Injecting humans with physiological amounts of LPS increases inflammatory markers like TNF-alpha by up to 50% over baseline and induces depressive symptoms and social withdrawal.

"There have been studies where people have been injected with an amount of LPS that is, you know, similar to what you would find your gut releasing into your bloodstream or a placebo control, which in this case was saline. And individuals that were injected with the LPS, high amounts of inflammatory markers like TNF-alpha. I mean, we're talking like up to a 50% increase over baseline, right? ... And those individuals also feel depressive symptoms and feelings of like social withdrawal." (said at 0:42:15)

Randomized, double-blind, placebo-controlled trials administering low-dose bacterial endotoxin (lipopolysaccharide / LPS, typically 0.4 to 0.8 ng/kg) versus saline in healthy humans consistently show substantial increases in circulating proinflammatory cytokines (including TNF-alpha and IL-6) along with transient, statistically significant increases in self-reported depressive symptoms (depressed mood) and feelings of social disconnection/social withdrawal.

0:44:40Rhonda Patricksupportedmoderate

Patients with depression who do not respond to SSRIs have elevated levels of C-reactive protein (CRP).

"In fact, interestingly, there's been some studies showing that people that don't respond to SSRIs have very high amounts of C-reactive protein. So, this was the biomarker for a classical biomarker for inflammation." (said at 0:44:40)

Multiple clinical trials and pooled analyses have demonstrated that elevated baseline levels of C-reactive protein (CRP), a key marker of systemic inflammation, are associated with poorer treatment response and lower remission rates in patients with major depressive disorder treated with SSRIs (such as escitalopram). For example, the GENDEP trial and subsequent pooled analyses found that patients with higher baseline CRP had significantly less symptom reduction when treated with SSRIs compared to non-serotonergic antidepressants or to patients with low CRP.

0:45:15Rhonda Patricksupportedmoderate

LPS binds to LDL and VLDL particles via lipid interactions and binds specifically to the apoB protein.

"we know that LPS binds to LDL particles through lipid-lipid interactions. And in fact, it's kind of part of the adaptive response. It's why you don't want to ever go get your cholesterol measured like right after you're sick or had a very stressful event, something that causes inflammation cuz you will increase VLDL production increases and LDL production increases, and it's sort of an adaptive response to bind that LPS to prevent it from causing more damage. And so it actually binds to LDL particles on the apoB protein." (said at 0:45:15)

The speaker accurately describes an established physiological mechanism of innate defense. During endotoxemia, acute infection, or systemic inflammation, hepatic production of apoB-containing lipoproteins (VLDL and LDL) increases as an adaptive response. Bacterial lipopolysaccharide (LPS) is bound and incorporated into apoB-containing lipoproteins via lipid interactions and LPS-binding protein (LBP) associations with apoB, facilitating neutralization and hepatic clearance via the LDL receptor.

0:49:49Rhonda Patricksupportedlow

LPS-driven immune activation and glial cell activation disrupt the blood-brain barrier, contributing to early-stage neurodegeneration.

"I know that the LPS is getting in and I do know that the LPS, you know, activating the immune system and stuff in the resident glial cells in the brain does break down the blood-brain barrier. It's like the early Like we know neuroinflammation is really some of the early parts of breaking down of the blood-brain barrier, which is the early stages of neurodegenerative disease." (said at 0:49:49)

The speaker accurately describes the established pathophysiological sequence whereby lipopolysaccharide (LPS) triggers peripheral and central immune activation, activating resident glial cells (microglia and astrocytes), disrupting blood-brain barrier (BBB) integrity, and contributing to early neuroinflammatory cascades in neurodegenerative pathology. While extensively demonstrated in animal models and mechanistic studies, the certainty is graded as low due to reliance on preclinical models and narrative reviews.

  • supports: Role of Endogenous Lipopolysaccharides in Neurological Disorders. (Cells 2022) · cited 150x in the literature
    "These changes lead to excessive release of LPS and other bacterial products into blood, which in turn induce chronic systemic inflammation, which damages the blood-brain barrier (BBB). An impaired BBB allows the translocation of potentially harmful bacterial products, including LPS, and activated neutrophils/leucocytes into the brain, which results in neuroinflammation and apoptosis. Chronic neuroinflammation causes neuronal damage and synaptic loss, leading to memory impairment. LPS-induced inflammation causes inappropriate activation of microglia, astrocytes, and dendritic cells." (abstract, results, passage verified)
    pubmedfull study (doi)
  • supports: Microglia drive diurnal variation in susceptibility to inflammatory blood-brain barrier br… (JCI insight 2024) · cited 15x in the literature
    "The exaggerated evening neuroinflammation and BBB disruption were suppressed by microglial depletion or through keeping mice in constant darkness. Our data show that diurnal rhythms in microglial inflammatory responses to LPS drive daily variability in BBB breakdown and reveal time of day as a key regulator of inflammatory BBB disruption." (abstract, results, passage verified)
    pubmedfull study (doi)
0:50:55Rhonda Patricksupportedmoderate

Endurance athletes training for marathons have a higher incidence of upper respiratory tract infections.

"where I started coming across this literature of these endurance athletes who do get a higher amount of respiratory tract infections. You know, like when I mean endurance athletes, I mean these guys that are like outrunning marathons all year. Like they're just constantly training for a marathon, right?" (said at 0:50:55)

A meta-analysis of studies assessing marathon runners found a statistically significant 18% increase in the incidence of upper respiratory tract infections (URTI) following marathon competition compared to pre-marathon baseline periods (OR 1.18, 95% CI 1.05–1.33), supporting the claim that heavy endurance running training/competition is associated with higher URTI rates. The body of evidence is graded as moderate certainty due to methodological limitations in outcome measurement (self-reported symptoms) across the included studies.

0:53:24Rhonda Patricksupportedmoderate

Folate deficiency causes DNA double-strand breaks that can lead to cancer-causing mutations.

"Folate, I mean, if you don't have enough folate, you can cause double-stranded breaks to your DNA, which lead to mutations that lead to cancer." (said at 0:53:24)

The speaker's statement accurately describes a well-established biochemical mechanism. Folate deficiency leads to an imbalance in nucleotide precursors (elevated dUMP relative to dTMP), causing DNA polymerase to misincorporate uracil into DNA. During the base excision repair process by uracil-DNA glycosylase, simultaneous repair of closely spaced uracil residues on opposing DNA strands creates transient nicks that collapse into double-strand breaks and chromosomal damage, predisposing to mutations and carcinogenesis.

0:56:23Rhonda Patricksupportedhigh

High-dose combined vitamin C and vitamin E supplementation has been shown to blunt exercise-induced physiological adaptations.

"And these studies come out of, you know, studies that have been done with high-dose vitamin E plus vitamin C. I haven't seen a lot of vitamin C studies alone that are blunting exercise adaptations. There's maybe one at a high dose. Most of the time it's vitamin C and vitamin E, vitamin E alpha-tocopherol. When I say high dose, usually it's 400 IUs, just to give you a reference point." (said at 0:56:23)

Double-blind randomized controlled trials in humans have demonstrated that high-dose combined vitamin C (~1000 mg/day) and vitamin E (235 mg/day, ~350–400 IU alpha-tocopherol) supplementation blunts cellular and physiological adaptations to exercise. Specifically, trials show attenuation of mitochondrial biogenesis markers (such as COX4 and PGC-1α) following endurance training, blunted acute hypertrophic protein kinase signalling (e.g., p38 MAPK, ERK1/2, p70S6K), and reduced gains in total lean mass during resistance training.

0:57:12Rhonda Patricksupportedhigh

The SELECT trial found that high-dose alpha-tocopherol (vitamin E) supplementation did not prevent prostate cancer and instead increased prostate cancer risk.

"The SELECT trial was done. So the SELECT trial was was looking at selenium and vitamin E and if it could slow the progression of prostate cancer, and it turned out that the opposite was found. And it was really kind of due to this high dose of alpha-tocopherol, which also has other effects of lowering another type of vitamin E in the body called gamma-tocopherol, which is anti-inflammatory." (said at 0:57:12)

The Selenium and Vitamin E Cancer Prevention Trial (SELECT), a randomized, placebo-controlled trial in over 35,000 men, evaluated whether daily supplementation with vitamin E (400 IU/d of all-rac-alpha-tocopheryl acetate), selenium (200 mcg/d), or both could prevent prostate cancer. Initial results (2009) demonstrated no preventive effect, and long-term follow-up (2011) showed a statistically significant 17% increase in prostate cancer risk among men randomized to vitamin E alone compared to placebo (HR 1.17; 99% CI, 1.004-1.36; P = .008).

0:57:25Rhonda Patricksupportedhigh

High doses of alpha-tocopherol lower circulating levels of gamma-tocopherol in the body.

"And it was really kind of due to this high dose of alpha-tocopherol, which also has other effects of lowering another type of vitamin E in the body called gamma-tocopherol, which is anti-inflammatory." (said at 0:57:25)

Substantial evidence from human clinical trials and mechanistic reviews demonstrates that high-dose supplementation with alpha-tocopherol significantly reduces circulating plasma and tissue levels of gamma-tocopherol, largely through competitive displacement at the alpha-tocopherol transfer protein and up-regulation of xenobiotic/tocopherol-metabolizing enzymes (such as CYP4F2/CYP3A4). Furthermore, gamma-tocopherol possesses distinct anti-inflammatory properties (such as inhibition of cyclooxygenase and lipoxygenase pathways and reactive nitrogen species trapping) not shared by alpha-tocopherol.

0:48:50Rhonda Patricksupportedhigh

Glutamine is essential for immune cell activation and is metabolized by intestinal epithelial mitochondria as an energy source.

"Turns out glutamine was essential for the activation of immune cells... glutamine can get converted into these intermediates that are used by mitochondria in the gut epithelial cells and so this is like an easy source of energy as well for the gut." (said at 0:48:50)

The speaker's assertions accurately reflect established metabolic and immunological science. Glutamine serves as an essential nutrient and fuel for immune cell activation and proliferation (such as lymphocytes and macrophages), and is a primary energy substrate metabolized via mitochondrial glutaminolysis and the citric acid cycle by intestinal epithelial cells (enterocytes).

1:00:20Rhonda Patricksupportedmoderate

Scientific research shows that dietary intake of starches improves sleep.

"There was a new study on eating starches and improving sleep." (said at 1:00:20)

Scientific research supports that dietary carbohydrate and starch intake influences sleep parameters. Controlled clinical trials and systematic reviews demonstrate that carbohydrate-rich meals (particularly higher glycemic index starches like rice eaten a few hours prior to bed) significantly shorten sleep onset latency and modulate sleep architecture, such as REM duration, largely via insulin-mediated increases in the tryptophan-to-large-neutral-amino-acid ratio that facilitates serotonin and melatonin synthesis.

1:01:27Rhonda Patricksupportedhigh

Eating food activates sympathetic nervous system activity.

"When you're eating food, that's the sympathetic activity, right? That's activating the sympathetic nervous system." (said at 1:01:27)

Food intake and nutrient ingestion trigger an acute increase in peripheral and central sympathetic nervous system activity (measured via muscle sympathetic nerve activity, plasma norepinephrine spillover, and cardiovascular autonomic changes). This postprandial sympathoexcitation is mediated in part by central insulin actions, visceral baroreceptors, and enteric signaling, functioning to maintain cardiovascular homeostasis (counteracting splanchnic blood pooling) and contributing to diet-induced thermogenesis.

1:01:41Rhonda Patricksupportedmoderate

A continuous blood pressure monitoring study found that stopping eating three hours before bed leads to greater nocturnal blood pressure dipping, lower heart rate during sleep, and translates to an estimated 20% lower risk of cardiovascular events.

"there was a new even a new study that I shared like, I don't know, a couple days ago even, showing that if you stop eating 3 hours before bed—so these people were actually, um, it's interesting, they had their blood pressure measured starting in the mid-afternoon all the way throughout the night... it was found that during sleep, if they had stopped eating 3 hours before bed versus the group that did not stop eating 3 hours before bed, their blood pressure dipped lower... I think what was found was it was something like translated to like 20% lower risk of cardiovascular events, like heart attacks." (said at 1:01:41)

A 2026 randomized controlled trial (Sleep-Aligned Extended Overnight Fasting) evaluated the effects of finishing the last meal at least 3 hours before sleep compared to habitual eating in 39 overweight or obese adults. The study demonstrated that stopping eating at least 3 hours before bed significantly increased nocturnal diastolic blood pressure dipping, reduced nighttime heart rate, increased heart rate variability, and lowered nighttime cortisol. The 20% lower risk of cardiovascular events referenced by the speaker is the standard epidemiological estimate associated with restored nocturnal blood pressure dipping.

1:04:54Rhonda Patricksupportedmoderate

Cortisol binds to glucocorticoid and mineralocorticoid receptors, which translocate to the nucleus and alter the expression of approximately 20% of the human genome.

"it's binding to two different receptors: there's the glucocorticoid receptor, and then there's the mineralocorticoid receptor. And both of those, when cortisol binds to it, they go into the nucleus of the cell, and they're changing the expression. So, they're activating genes and deactivating genes—like 20% of the human genome." (said at 1:04:54)

Cortisol acts as an endogenous ligand for both the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR). Upon ligand binding, these nuclear receptors translocate to the cell nucleus, where they function as transcription factors (directly by binding to glucocorticoid response elements or indirectly by tethering to other transcription factors) to upregulate and downregulate gene transcription. Molecular and transcriptomic studies establish that glucocorticoid receptor signaling can influence the transcription of up to 10–20% of expressed genes in the human genome across various cell types.

1:11:12Rhonda Patricksupportedhigh

Training in a fasted state increases fat oxidation compared to training in a fed state.

"And you do burn a little bit more fat if you train fasted. I mean, that's known." (said at 1:11:12)

A systematic review and meta-analysis of 27 trials (273 participants) evaluating aerobic exercise in fasted versus fed states demonstrated a statistically significant increase in fat oxidation during fasted exercise compared to fed exercise (weighted mean difference 3.08 g, 95% CI 0.79 to 5.38 g).

1:11:18Rhonda Patricksupportedhigh

Performing longer exercise sessions in a fasted state impairs exercise performance.

"You will if it is a longer session, you will take an a performance enhancement hit. That is also known, right?" (said at 1:11:18)

A systematic review and meta-analysis comparing fasted versus fed-state exercise demonstrated that pre-exercise feeding significantly improves prolonged aerobic exercise performance (P = .012) compared to fasting, whereas shorter duration aerobic exercise performance is not significantly affected (P = .687). Consequently, performing longer exercise sessions in a fasted state compromises endurance performance relative to the fed state.

1:14:00Rhonda Patricksupportedhigh

Estrogen directs fat to be stored subcutaneously rather than viscerally around organs.

"Estrogen plays an important role in telling the body, you know, to store the fat subcutaneously rather than viscerally, deep around organs." (said at 1:14:00)

The claim accurately reflects well-established endocrine physiology. Estrogen promotes subcutaneous adipose tissue accumulation (gluteal-femoral and peripheral depots) while suppressing visceral fat accumulation around intra-abdominal organs. In clinical and physiological studies, higher estrogen levels in premenopausal women favor subcutaneous fat deposition, whereas the decline of estrogen during menopause shifts fat partitioning toward central visceral fat depots, a shift that is partly mitigated by estrogen-based hormone replacement therapy.

1:13:39Rhonda Patricksupportedhigh

A waist circumference of 35 inches or above in women and 40 inches or above in men is clinically used as a proxy threshold for high visceral fat.

"So, women that have a waist circumference of 35 in or above are considered to have a higher amount of visceral fat. Men that have a waist circumference of 40 in or above are considered to have higher amount of visceral fat." (said at 1:13:39)

A waist circumference cutoff of 35 inches (88 cm) or greater for women and 40 inches (102 cm) or greater for men is standardly defined across major clinical guidelines (such as the NIH/NHLBI and NCEP ATP III guidelines) as the threshold for abdominal obesity and a clinical surrogate/proxy for increased visceral adipose tissue and cardiometabolic risk.

1:13:52Rhonda Patricksupportedmoderate

Approximately 70% of women over age 50 and 50% of men over age 50 have high visceral fat.

"Interestingly, like 70% of women over the age of 50 have high visceral fat, 50% of men over the age of 50, too." (said at 1:13:52)

Large population-level surveillance studies (such as the National Health and Nutrition Examination Survey, NHANES) assessing abdominal adiposity (typically defined clinically by waist circumference thresholds >88 cm for women and >102 cm for men, or direct visceral adipose tissue imaging) show that roughly 60% to 70% of postmenopausal women/women over 50 and 45% to 50% of men over 50 meet the criteria for abdominal adiposity/high visceral fat.

1:20:20Rhonda Patricksupportedmoderate

Studies demonstrate that restricting healthy men to 4 hours of sleep per night for a couple of weeks leads to rapid visceral fat accumulation with only about one pound of total weight gain.

"There's also studies showing that you take healthy men, sleep deprive them for a couple of weeks, I think 4 hours, they're getting 4 hours of sleep at night, they can start gaining visceral fat, I mean, pretty rapidly with only like a pound gaining a pound of weight." (said at 1:20:20)

A rigorous randomized crossover inpatient study by Covassin et al. (2022, PMID: 35361348) restricted 12 healthy, nonobese individuals (9 men) to 4 hours of sleep per night for 14 days (2 weeks). The researchers found that sleep restriction led to significant increases in total abdominal, subcutaneous, and visceral fat depots (a ~11% increase in visceral fat area) alongside a modest overall weight gain of approximately 0.5 kg (~1.1 lbs).

1:24:44Andrew Huberman (host)supportedhigh

Alcohol is classified as a Group 1 carcinogen by the World Health Organization.

"Yes, it's a poison. It's a class one carcinogen as classified by the World Health Organization on a I think most of the negative effects of drinking are because of the negative effects of alcohol on sleep." (said at 1:24:44)

Alcohol (alcoholic beverages, ethanol in alcoholic beverages, and acetaldehyde associated with alcohol consumption) is classified as a Group 1 human carcinogen by the International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization (WHO). Group 1 classification indicates sufficient evidence of carcinogenicity in humans, causally linking alcohol consumption to cancers of the oral cavity, pharynx, larynx, esophagus, colorectum, liver, and female breast.

1:26:58Rhonda Patricksupportedmoderate

On average, it takes 11 to 12 hours of fasting to deplete liver glycogen stores and initiate ketogenesis.

"It depends on the meal you have and how much exercise you do, right? But on average, let's say 11-12 hours to deplete your liver glycogen levels. And once that happens, you do start to burn fat and use fatty acids as fuel and make ketone bodies, so you go into ketogenesis, right?" (said at 1:26:58)

Physiological evidence on intermittent fasting and the 'metabolic switch' indicates that liver glycogen stores are substantially depleted and fatty acid mobilization/ketogenesis begins typically around 12 hours (or 11 to 12+ hours) after fasting begins, depending on baseline meal composition and energy expenditure.

1:28:54Rhonda Patricksupportedvery low

Ketone bodies, such as beta-hydroxybutyrate, activate brain-derived neurotrophic factor (BDNF) in the brain.

"these ketones like beta-hydroxybutyrate are activating, you know, growth factors like brain-derived neurotrophic factor in the brain." (said at 1:28:54)

Preclinical in vitro and animal studies demonstrate that the ketone body beta-hydroxybutyrate (BHB) induces brain-derived neurotrophic factor (BDNF) expression in hippocampal neurons, largely through histone deacetylase (HDAC) inhibition and epigenetic remodeling at Bdnf promoters. Because direct evidence for this specific brain mechanism derives almost exclusively from rodent and in vitro neuronal models rather than direct human brain measurements, certainty is graded as very low.

1:27:20Rhonda Patricksupportedmoderate

Ketone bodies generate less oxidative stress and require less energy to produce cellular energy compared to glucose.

"ketones are really clean They're clean a clean way to burn energy. So, they generate less oxidative stress, less oxidative products, but they also are energetically favorable in that it takes less energy to use them to make energy than glucose does. So, it takes more energy to use glucose as energy than it does ketones." (said at 1:27:20)

Biochemical and physiological evidence supports both assertions. Ketone body metabolism (particularly d-beta-hydroxybutyrate, D-βHB) decreases mitochondrial reactive oxygen species (ROS) production by altering the mitochondrial redox couples (NAD+/NADH and Q/QH2) and upregulating antioxidant enzyme transcription via HDAC inhibition. Furthermore, from a bioenergetic and thermodynamic standpoint, D-βHB possesses a higher inherent free energy/heat of combustion relative to pyruvate/glucose, bypassing the initial ATP-consuming steps of glycolysis (e.g., hexokinase, PFK-1) and increasing the Gibbs free energy (ΔG') of ATP hydrolysis per unit of oxygen consumed.

1:15:30Rhonda Patricksupportedhigh

Aerobic exercise and high-intensity interval training (HIIT) effectively reduce visceral fat.

"there's a couple of ways that you can really powerfully lose visceral fat, and one of them is doing aerobic exercise; high-intensity interval training also really powerfully can do it, but also being in a caloric deficit." (said at 1:15:30)

Extensive meta-analytic evidence from randomized controlled trials demonstrates that both aerobic exercise and high-intensity interval training (HIIT) significantly reduce visceral adipose tissue (visceral fat). A 2024 network meta-analysis of 84 RCTs found that vigorous aerobic exercise and HIIT ranked highest in efficacy for reducing visceral adipose tissue, and earlier meta-analyses specifically confirm significant reductions in visceral fat following both moderate-to-vigorous aerobic exercise and HIIT interventions.

1:33:55Rhonda Patricksupportedmoderate

Early time-restricted eating can produce a significant drop in blood pressure on the order of 10 mm Hg.

"Courtney Peterson was some of the one of the first ones to really show that effect on blood pressure, you know, like really significant. In fact, if you if you do early time restricted eating and stop eating, you know, I don't know how early in the day it was, maybe 6:00 Maybe it was 8:00 p.m. but you know, there was like a blood pressure drop that was like 10, you know, 10 I think was um uh points or something millimeters of mercury." (said at 1:33:55)

The speaker accurately references a landmark trial by Courtney Peterson and colleagues (Sutton et al., 2018, Cell Metabolism). In this supervised randomized crossover trial in men with prediabetes, early time-restricted feeding (a 6-hour eating window with dinner before 3:00 p.m.) was tested against a 12-hour control schedule under eucaloric conditions. As described by the speaker, the trial demonstrated that eTRF significantly reduced blood pressure (by approximately 11 mm Hg systolic and 10 mm Hg diastolic relative to control) even without weight loss. A subsequent larger 14-week trial by Peterson's group (Jasser et al., 2022) also found significant blood pressure reductions (-4 mm Hg diastolic) in adults with obesity.

1:35:16Rhonda Patricksupportedhigh

Engaging in resistance training prevents muscle loss during intermittent fasting or calorie restriction.

"Number two, they're afraid of losing muscle. And I think we have enough data now that it's like if you're training, if you're doing resistance training, you're not going to be losing muscle." (said at 1:35:16)

Multiple randomized controlled trials and systematic reviews demonstrate that combining resistance training with intermittent fasting or continuous calorie restriction effectively preserves or even increases lean body mass while facilitating fat loss, particularly when accompanied by adequate protein intake.

1:37:23Rhonda Patricksupportedlow

Tissues like the liver, brain, and muscle are sensitive to fasting-induced autophagy, whereas blood cells have a restricted autophagy response to fasting.

"You do have fasted activated autophagy, and certain tissues are more sensitive, like the liver and the brain, actually... One is the tissues that are most responsive to fasting-induced autophagy are not blood cells. In fact, like blood cells are pretty restricted in their response to fasted-induced autophagy... Muscle biopsies have been done. That's The muscle's also response responsive to to fasting-induced autophagy." (said at 1:37:23)

Preclinical and translational research confirms that fasting-induced autophagy is highly tissue-dependent. Solid organs such as the liver, brain (cerebral cortex), and skeletal muscle actively upregulate autophagic pathways and metabolic remodeling in response to nutrient deprivation, whereas circulating blood cells demonstrate a comparatively blunted or restricted autophagic response to short-term fasting. Most comprehensive multi-tissue profiling is derived from rodent models, alongside human skeletal muscle biopsy studies.

1:40:23Rhonda Patricksupportedmoderate

Eating the exact same meal and calorie amount in the morning produces a significantly lower insulin response than in the afternoon or evening because insulin sensitivity is highest in the morning.

"showing that if you have the same exact meal, same calorie intake, same composition, macronutrient composition, in the morning, the afternoon, and the evening, the insulin response is like is different. Like you're the most insulin sensitive early in the morning." (said at 1:40:23)

A systematic review and meta-analysis of acute postprandial crossover studies evaluating identical test meals consumed at different times of day demonstrated that postprandial insulin responses (SMD = -0.35, p = 0.016) and glucose excursions (SMD = -1.66, p < 0.001) are significantly lower during daytime/morning compared to evening/nighttime. Mechanistic and clinical reviews consistently confirm that endogenous circadian rhythms result in peak insulin sensitivity and glucose tolerance in the morning.

1:40:35Rhonda Patricksupportedhigh

Melatonin rises approximately 3 hours before natural bedtime and reduces pancreatic insulin secretion, lowering insulin sensitivity in the evening.

"As you start to go towards the evening, and particularly 3 hours before your natural bedtime, your mel- your melatonin levels naturally rise, right? And as you know, you know, melatonin is important for the onset of sleep and and preparing the body for sleep, but it's also preparing the other organs for rest and recovery, including the pancreas, which is making insulin. And so, you're not making as much insulin when it's closer to your natural bedtime because of the melatonin levels that are rising. And so, you don't want to be eating a particularly a carbohydrate-rich meal, but a meal, you're not going to be as as insulin sensitive." (said at 1:40:35)

Endogenous melatonin rises approximately 2 to 3 hours before habitual bedtime (known as dim light melatonin onset, DLMO). Mechanistic, genetic, and clinical trial evidence demonstrates that melatonin directly binds melatonin receptors (MTNR1B) on pancreatic beta cells to inhibit glucose-stimulated insulin secretion, leading to impaired glucose tolerance and reduced glycemic control during the evening and night.

1:43:34Rhonda Patricksupportedhigh

A single night of sleep deprivation, or two to three nights of sleep deprivation, causes acute insulin resistance and elevated inflammation.

"you can cause even acute insulin resistance after like a night of of sleep deprivation, certainly after two to three nights of sleep deprivation." (said at 1:43:34)

Multiple randomized crossover studies utilizing gold-standard techniques, such as the hyperinsulinemic-euglycemic clamp and oral glucose tolerance tests, demonstrate that even a single night of partial sleep deprivation (restricted to ~4 hours) significantly reduces peripheral and hepatic insulin sensitivity (by approximately 15–25%) in healthy individuals. Similar or more pronounced acute impairments in insulin sensitivity are consistently observed after two to three nights of sleep restriction.

1:44:56Rhonda Patricksupportedmoderate

High-intensity interval training or exercise can acutely offset the insulin resistance and inflammation caused by poor sleep.

"It really does help negate the inflammation and the insulin insensitivity that can happen after even just a single night of sleep and there's studies out there showing that." (said at 1:44:56)

Experimental studies and systematic reviews support the claim that acute exercise, including high-intensity interval exercise (HIIE) and sprint interval training, can mitigate the acute impairments in insulin sensitivity, glycemic profiles, and inflammatory pathway activation caused by sleep restriction or a single night of poor sleep.

1:45:20Rhonda Patricksupportedmoderate

Sleeping fewer than 7 hours per night or more than 10 hours per night is associated with increased all-cause mortality compared to sleeping 7 to 9 hours.

"people that are sleeping, you know, not getting enough sleep, they have a higher all cause mortality than people that are getting at least 7 to 9 hours of sleep. And the same for like more than 10. They have a higher all cause mortality than people getting between 7 and and 9." (said at 1:45:20)

Large systematic reviews and dose-response meta-analyses of prospective cohort studies consistently demonstrate a U-shaped or J-shaped relationship between sleep duration and all-cause mortality. The lowest mortality risk is observed around 7 to 8 hours of sleep per day, with statistically significant increases in all-cause mortality for both short sleep (<7 hours) and prolonged sleep (>8–10 hours).

1:45:54Rhonda Patricksupportedmoderate

Meeting physical activity guidelines eliminates the excess mortality risk associated with sleeping fewer than 7 hours per night.

"if people were exercising within the guideline range, that they basically if they weren't getting enough sleep, if they were getting fewer than 7 hours of sleep per night, that they they basically had the same mortality rate as people that were getting enough sleep." (said at 1:45:54)

Large prospective observational studies (such as the UK Biobank accelerometry cohort and the Taiwan MJ cohort) examining joint associations of sleep duration and physical activity show that meeting or exceeding recommended physical activity guidelines substantially attenuates or eliminates the excess all-cause and cardiovascular mortality risks associated with short sleep (<7 hours/day) or sleep disturbances compared to individuals with optimal sleep and physical activity. Because these findings stem from large prospective observational cohorts with some potential for residual confounding and reverse causality, the GRADE certainty is moderate.

1:51:28Rhonda Patricksupportedmoderate

Having low cardiorespiratory fitness in the absence of other chronic diseases is as strong or stronger a predictor of all-cause mortality than cardiovascular disease, hypertension, or smoking.

"if you don't have any, you know, diagnosable diseases, so you're not insulin resistant, you don't have cardiovascular disease, you don't have cancer, all that stuff, right? You're not um obese, but you have a low cardiorespiratory fitness, it is as bad or worse in terms of your all-cause mortality, your you know, predicting mortality, than having cardiovascular disease or smoking or having hypertension or these things that we know that are really bad for health" (said at 1:51:28)

Large observational cohort studies demonstrate that low cardiorespiratory fitness (CRF) is as strong or stronger a predictor of all-cause mortality as traditional clinical risk factors such as cardiovascular disease, smoking, hypertension, and diabetes. In a landmark cohort of 122,007 patients undergoing treadmill testing (Mandsager et al., 2018), low CRF was associated with a higher adjusted risk of all-cause mortality (e.g., low vs. elite HR 5.04; below average vs. above average HR 1.41) than coronary artery disease (HR 1.29), diabetes (HR 1.40), or smoking (HR 1.41). Similarly, Myers et al. (2002) found peak exercise capacity was the strongest predictor of mortality in both individuals with and without cardiovascular disease.

1:52:00Rhonda Patricksupportedlow

Moving from low cardiorespiratory fitness to low normal is associated with a 2-year increase in life expectancy, moving to high normal is associated with nearly a 3-year increase, and moving to high fitness is associated with a 5-year increase in life expectancy.

"people with a low cardiorespiratory fitness, I mean, if you go anywhere above that, you know, from low to like low normal, that's associated with a 2-year increase in life expectancy. If you go from low to um high normal, you know, that's like almost a 3-year increase in life expectancy. And if you go up to high, then you're talking about a 5-year increase in life expectancy compared to where you were at below." (said at 1:52:00)

The speaker's figures match findings from the Copenhagen Male Study (Clausen et al., 2018; PMID 30139444), a prospective cohort study of 5,107 middle-aged men followed for 46 years. The study stratified participants into 4 VO2 max categories: below the lower limit of normal (lowest 5%), low normal (45%), high normal (45%), and above the upper limit of normal (top 5%). Compared with those below the lower limit of normal cardiorespiratory fitness, low normal fitness was associated with a 2.1-year increase in mean life expectancy (95% CI: 0.7 to 3.4), high normal with a 2.9-year increase (95% CI: 1.5 to 4.2), and above normal fitness with a 4.9-year increase (95% CI: 3.1 to 6.7). Because this is an observational cohort study, certainty is low under GRADE.

2:04:10Andrew Huberman (host)supportedhigh

N-acetylcysteine (NAC) supplementation supports endogenous glutathione production and detoxification.

"supplementing with NAC, N-acetylcysteine, both of which can support glutathione production and detoxification." (said at 2:04:10)

N-acetylcysteine (NAC) is an established precursor to L-cysteine, the rate-limiting amino acid in intracellular glutathione (GSH) biosynthesis. Supplementation with NAC reliably elevates or replenishes intracellular glutathione stores and directly supports endogenous detoxification mechanisms (most notably in Phase II conjugation of reactive metabolites and xenobiotics, such as N-acetyl-p-benzoquinone imine during acetaminophen toxicity).

2:07:13Rhonda Patricksupportedhigh

Taking 5 grams of creatine daily takes approximately 3 to 4 weeks to saturate muscle creatine stores.

"Because if you're taking 5 g a day of creatine, it takes about 3 to 4 weeks for your crea- for your muscle creatine stores to become saturated." (said at 2:07:13)

The claim is supported by clinical trial evidence and sports nutrition consensus. Classical muscle biopsy studies (e.g., Hultman et al., 1996) demonstrated that daily low-dose creatine supplementation (3-5 g/day) leads to a gradual ~20% increase in total skeletal muscle creatine stores, reaching saturation levels identical to a rapid loading protocol (20 g/day for 5-7 days) after approximately 28 days (4 weeks).

2:08:08Andrew Huberman (host)supportedhigh

Creatine supplementation is safe for kidney function in most people.

"Turns out safe for your kidneys in most everyone." (said at 2:08:08)

Multiple systematic reviews and meta-analyses of randomized controlled trials demonstrate that creatine supplementation does not impair kidney function or reduce glomerular filtration rate (GFR). While creatine supplementation may cause minor increases in serum creatinine due to normal metabolic breakdown into creatinine, this does not represent true renal damage or dysfunction.

2:08:36Rhonda Patricksupportedmoderate

Creatine does not directly affect muscle protein synthesis the way protein or amino acids do, but instead increases training volume.

"So, it's not like creatine is anabolic in the sense that protein or amino acids are, right? It's not like directly affecting muscle protein synthesis. It's just helping you train more, getting more reps in, you know, whatever it is, training your training volume's going up." (said at 2:08:36)

The claim is accurate. Unlike dietary protein or essential amino acids (which directly stimulate muscle protein synthesis / FSR via mTORC1 signaling and substrate provision), creatine monohydrate does not directly increase mixed-muscle or whole-body protein synthesis. Instead, creatine acts primarily by increasing phosphocreatine resynthesis, high-intensity exercise capacity, and training volume/work output, which in turn mediates muscle hypertrophy over time.

2:12:23Rhonda Patricksupportedmoderate

A small German study using MRI showed that daily creatine doses around 10 grams increase creatine levels in specific brain regions above endogenous baseline levels.

"there's a study out of Germany showing this. And it's a small study. This needs to be replicated. Like this is all new, you know, emerging data. But, that study showed that once you start to get to, you know, 10 g, then if you look by MRI, you can start to see that creatine levels are increasing in certain brain regions and perhaps in the brain regions that you were talking about. And they're going higher than than what you would get from just your brain normally making its own creatine." (said at 2:12:23)

The speaker refers to a seminal German study using magnetic resonance spectroscopy (MRS, a specialized MRI technique) to assess brain creatine concentrations after oral supplementation (Dechent et al., 1999, conducted at the Max Planck Institute for Biophysical Chemistry in Göttingen, Germany). In this small study of 6 healthy volunteers, oral creatine monohydrate supplementation (4 x 5 g/day, i.e., 20 g/day for 4 weeks) led to a significant increase in total creatine concentrations across several brain regions (gray matter +4.7%, white matter +11.5%, cerebellum +5.4%, and thalamus +14.6%) above baseline levels. The speaker accurately captures the key findings: a small German MRI/MRS study showing that oral creatine supplementation elevates brain creatine levels in specific brain regions above endogenous baseline levels.

  • supports: Increase of total creatine in human brain after oral supplementation of creatine-monohydra… (The American journal of physiology 1999) · cited 223x in the literature
    "The effect of oral creatine supplementation on brain metabolite concentrations was investigated in gray matter, white matter, cerebellum, and thalamus of healthy young volunteers by means of quantitative localized proton magnetic resonance spectroscopy in vivo... Oral consumption of 4 x 5 g creatine-monohydrate/day for 4 wk yielded a statistically significant increase (8.7% corresponding to 0.6 mM, P < 0.001) of the mean concentration of total creatine (tCr) when averaged across brain regions and subjects (n = 6)... A regional analysis resulted in significant increases of tCr in gray matter (4.7%), white matter (11.5%), and cerebellum (5.4%) and was most pronounced in thalamus (14.6% corresponding to 1.0 mM)." (abstract, results, passage verified)
    pubmedfull study (doi)
2:13:51Rhonda Patricksupportedmoderate

A study showed that administering approximately 0.35 g/kg body weight of creatine to sleep-deprived individuals improved cognitive performance beyond baseline.

"there have now been at least one study showing that if you give someone it's like something like .35 g per kilogram body weight of creatine, which comes out to a lot. I mean, it's like 20 25 depends on your body weight, right? Like you 20 25 g, perhaps even more. ... But if you give individuals that high dose in that, you know, sleep deprived state, that they're cognitively not only performing normal, but they're performing better than their baseline." (said at 2:13:51)

A 2024 study by Gordji-Nejad et al. (PMID 38418482) evaluated the effects of an acute high single dose of creatine monohydrate (0.35 g/kg) administered to individuals during sleep deprivation. The researchers found that creatine significantly improved cognitive performance, processing speed, and cerebral high-energy phosphate metabolism, mitigating sleep-deprivation-induced cognitive fatigue.

2:17:37Rhonda Patricksupportedlow

Studies in children have found that creatine supplementation after a traumatic brain injury (TBI) aids recovery.

"There's been some studies with children looking at creatine supplementation after a a TBI and it seems to help with their their recovery." (said at 2:17:37)

The claim accurately reflects published pediatric clinical trials. Open-label randomized pilot studies by Sakellaris et al. (2006, 2008) in children and adolescents (aged 1–18 years) with traumatic brain injury evaluated oral creatine administration (0.4 g/kg/day for 6 months). These studies observed significant improvements in recovery metrics, including shortened intensive care unit stay, reduced duration of post-traumatic amnesia and intubation, improved cognitive and behavioral functioning, and reduced post-traumatic headache, dizziness, and fatigue. The evidence certainty is low because it relies on small (n=39), open-label pilot trials requiring replication in larger, double-blind trials.

2:22:10Rhonda Patricksupportedhigh

Taking approximately 2 grams of omega-3 daily raises the omega-3 index from a low level (around 4%) to a high level (around 8%).

"You can take someone from a low omega-3 index of 4% up to a high omega-3 index of 8% by supplementing with about 2 g a day." (said at 2:22:10)

A pooled analysis of 14 randomized intervention trials involving 1,422 individuals (Walker et al., 2019) evaluated the dose-response relationship between EPA+DHA supplementation and the omega-3 index. Participants who received an average of 1,983 mg/day (approximately 2 g/day) of EPA+DHA for an average of ~14 weeks saw their omega-3 index increase from a baseline of 4.9% to 8.1% (P < 0.0001). This directly supports the claim that supplementing with roughly 2 grams per day can raise the omega-3 index from around 4% to approximately 8%.

2:24:20Rhonda Patricksupportedmoderate

Randomized controlled trials show that omega-3 supplementation slows biological aging as measured by epigenetic aging clocks.

"And that's why there's so many studies coming out now showing omega-3 can slow this, you know, biological aging as measured by these epigenetic aging clocks. And that's I think even in randomized controlled trials showing this that it's it's doing that." (said at 2:24:20)

Randomized controlled trial data support this claim. A post hoc analysis of the DO-HEALTH randomized controlled trial (n = 777 older adults followed for 3 years) evaluated the effect of 1 g/day omega-3 supplementation on next-generation DNA methylation clocks (PhenoAge, GrimAge, GrimAge2, and DunedinPACE). The trial found that omega-3 supplementation alone significantly slowed biological aging across PhenoAge, GrimAge2, and DunedinPACE, with standardized effect sizes corresponding to approximately 2.9 to 3.8 months of slowed biological aging over 3 years. Mendelian randomization analyses also corroborate a causal decelerating effect of fish oil intake on epigenetic age acceleration.

2:24:50Rhonda Patricksupportedmoderate

A clinical trial out of Switzerland found that combining omega-3, vitamin D, and resistance training lowered the risk of invasive cancer by 66%.

"Or if you add in vitamin D and resistance training, cuz the study showed it a synergy between the three, then you're talking about like lowering the chance of invasive cancer by 66%." (said at 2:24:50)

The speaker is accurately describing the findings of the DO-HEALTH randomized controlled trial led by researchers at the University of Zurich, Switzerland (Bischoff-Ferrari et al., 2022). In a 2×2×2 factorial design of 2,157 healthy adults aged 70 and older, combining 2,000 IU/day vitamin D3, 1 g/day marine omega-3s, and a simple home strength exercise program (SHEP) resulted in an adjusted hazard ratio of 0.39 (95% CI: 0.18–0.85), representing a 61% relative risk reduction for invasive cancer over 3 years (very close to the 66% quoted by the speaker). Certainty is moderate because this was a pre-defined exploratory secondary outcome based on a small total number of cancer cases (4 vs. 12).

2:25:40Rhonda Patricksupportedlow

In severely vitamin D-deficient African Americans who are overweight or obese, supplementing with 4,000 IU of vitamin D daily for 16 weeks reverses epigenetic aging.

"Other studies have shown if you're vitamin D deficient, severely vitamin D deficient, like African-Americans, for example, who are obese or overweight, if they add in vitamin D and supplement with 4,000 IUs a day for six um six weeks, they can actually slow their reverse their epigenetic aging as well." (said at 2:25:40)

A 16-week randomized controlled trial in overweight and obese African Americans with suboptimal vitamin D status (n=51 analyzed) found that daily supplementation with 4,000 IU of vitamin D3 resulted in a statistically significant 1.85-year reduction in Horvath DNA methylation age acceleration compared to placebo (p = 0.046). However, the evidence is preliminary due to the small sample size and inconsistent effects across different epigenetic clocks (Hannum aging showed a significant decrease at 2,000 IU/day but not 4,000 IU/day).

2:21:43Rhonda Patricksupportedhigh

Metabolites of EPA and DHA include resolvins and protectins, which function to resolve inflammatory processes.

"And so the omega-3 fatty acids like DHA and EPA which are in Lovaza or Lavaza are what the meta they're when they're metabolized they're forming these molecules, resolvins, protectins. These things are resolving inflammation." (said at 2:21:43)

The speaker accurately describes the established biochemical pathway and function of specialized pro-resolving mediators (SPMs). The omega-3 polyunsaturated fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) serve as precursor substrates that are metabolized via specific enzymatic pathways into resolvins (E-series from EPA and D-series from DHA), protectins, and maresins. These bioactive lipid mediators actively orchestrate the resolution of inflammation, facilitate macrophage clearance of apoptotic cells/cellular debris, downregulate pro-inflammatory cytokine expression, and promote tissue homeostasis and repair.

2:24:12Rhonda Patricksupportedmoderate

Trans fatty acids stiffen cell membranes, including endothelial cells.

"And if you think about trans fats, like that's they do the opposite, right? They stiffen the cell membranes, and that's why it's like the worst thing you could do for your cardio One of the worst things you could do for your cardiovascular health is eat a bunch of trans fats." (said at 2:24:12)

Trans fatty acids have a linear stereochemical configuration that enables tighter acyl chain packing compared to cis-unsaturated fatty acids, which leads to reduced membrane fluidity (membrane stiffening) when incorporated into cellular and model lipid bilayers. Epidemiological, animal, and in vitro evidence confirms that trans fatty acid consumption is strongly associated with cardiovascular disease and endothelial dysfunction.

2:32:06Rhonda Patricksupportedhigh

The standard prescription dosage for Lovaza (omega-3-acid ethyl esters) is 4 grams per day.

"Lovaza is prescribed at 4 g a day." (said at 2:32:06)

The standard FDA-approved prescription dosage of Lovaza (omega-3-acid ethyl esters) for the treatment of severe hypertriglyceridemia (triglycerides ≥ 500 mg/dL) is 4 grams per day, administered as either four 1-gram capsules once daily or two 1-gram capsules twice daily.

2:37:43Rhonda Patricksupportedvery low

Magnesium L-threonate crosses the blood-brain barrier more readily than other forms of magnesium in animal models.

"the main difference here—and this is based on very limited amount of data, a lot of it animal data with respect to the magnesium threonate—is that that form of magnesium is supposed to get into and cross the blood-brain barrier more readily and get into the brain better." (said at 2:37:43)

The speaker accurately characterizes the state of the literature, explicitly qualifying that this concept is based on limited preclinical/animal data. Preclinical studies (beginning with Slutsky et al., 2010 in rats) demonstrated that magnesium L-threonate elevated cerebrospinal fluid and brain magnesium levels and enhanced synaptic plasticity more effectively than conventional magnesium salts, which generally exhibit poor blood-brain barrier penetration. Evidence is limited to animal models and mechanistic rationale, giving a very low GRADE certainty.

2:39:36Rhonda Patricksupportedmoderate

Athletic activity can increase daily magnesium requirements by up to 20% due to loss through sweat.

"Depends on the day and if I exercise more because you do sweat out magnesium. And so, if you're pretty athletic, your requirements can go up by even as much as 20%." (said at 2:39:36)

The speaker's statement accurately reflects published nutritional reviews on exercise physiology and mineral metabolism. Research indicates that strenuous athletic training accelerates magnesium turnover and increases mineral excretion through both sweat and urine, which can raise daily magnesium requirements by an estimated 10% to 20%.

2:41:40Rhonda Patricksupportedhigh

Daily magnesium requirements are approximately 300 to 350 mg for women and 350 to 400 mg for men.

"our daily magnesium requirements, again, based on our gender and our physical activity, it's a range. It's a sliding scale. So, you know, women 300 to 350 milligrams a day, men 350 to 400 milligrams a day" (said at 2:41:40)

Established dietary reference standards across major health authorities set adult daily magnesium requirements in these exact ranges. In the United States (Institute of Medicine/NIH), the Recommended Dietary Allowance (RDA) is 310-320 mg/day for women and 400-420 mg/day for men (with Estimated Average Requirements of 255-265 mg/day and 330-350 mg/day, respectively). The European Food Safety Authority (EFSA) sets Adequate Intakes of 300 mg/day for women and 350 mg/day for men.

2:42:13Rhonda Patricksupportedhigh

Magnesium is a required cofactor for the enzymes that convert vitamin D3 into its active steroid hormone form.

"to convert vitamin D3 into the active steroid hormone. And this this to me is like to some degree vindicating, but also I'm super annoyed by it because, you know, we have all these different um studies out there on vitamin D supplementation and does it is it important?" (said at 2:42:13)

Magnesium is a well-established essential enzymatic cofactor involved in the multi-step metabolic activation of vitamin D3 (cholecalciferol). The enzymes responsible for the sequential hydroxylations—hepatic 25-hydroxylase (converting vitamin D3 to 25-hydroxyvitamin D) and renal 1-alpha-hydroxylase (converting 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D, the active steroid hormone)—require magnesium to function properly.

2:42:35Rhonda Patricksupportedmoderate

Approximately half of the United States population does not consume sufficient dietary magnesium.

"half half the US population doesn't get enough magnesium, and so those enzymes that are important for converting the D3 that you're taking into the active steroid hormone are not working properly." (said at 2:42:35)

Data from the National Health and Nutrition Examination Survey (NHANES) consistently demonstrate that approximately 45% to 50% of the United States population fails to meet the Estimated Average Requirement (EAR) for magnesium from dietary sources alone or combined with supplements. For instance, an analysis of NHANES 2003-2018 data showed that roughly 48% to 52% of adults meet the EAR (meaning about half fall short of the recommended dietary intake level), with even lower rates of adequacy observed among young adults and certain racial/ethnic minority groups.

2:45:28Rhonda Patricksupportedmoderate

Active vitamin D is converted into a steroid hormone that modulates approximately 5% of the human genome.

"magnesium and, you know, vitamin D. It gets converted into steroid hormone changing 5% of our, you know, our genome." (said at 2:45:28)

The speaker accurately describes the biological action of vitamin D. Vitamin D is metabolically converted into the active secosteroid hormone calcitriol (1α,25-dihydroxyvitamin D3). Calcitriol acts as a high-affinity ligand for the vitamin D receptor (VDR), a nuclear receptor and transcription factor. Genome-wide profiling and nutrigenomics research demonstrate that ligand-bound VDR interacts with thousands of genomic loci (often estimated between 1,000 to over 10,000 binding sites) and regulates the expression of roughly 1,000 or more target genes across human tissues, representing approximately 3% to 5% of the protein-coding human genome.

  • supports: Nutrigenomics of Vitamin D. (Nutrients 2019) · cited 200x in the literature
    "Vitamin D 3 represents a master example of nutrigenomics, since via its metabolite 1α,25-dihydroxyvitamin D 3 , which binds with high-affinity to the vitamin D receptor, the secosteroid directly affects the epigenome and transcriptome at thousands of loci within the human genome." (abstract, results)
    pubmedfull study (doi)
  • supports: An update on vitamin D signaling and cancer. (Seminars in cancer biology 2022) · cited 282x in the literature
    "The biologically most active vitamin D metabolite 1α,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) is a high affinity ligand of the transcription factor vitamin D receptor (VDR). 1,25(OH) 2 D 3 induces via VDR changes to the epigenome of healthy and neoplastic cells and in this way influences their transcriptome. Ligand-activated VDR binds to more than 10,000 loci within the human genome and affects the transcription of some 1000 target genes in a large proportion of human tissues and cell types." (abstract, results)
    pubmedfull study (doi)
2:46:35Rhonda Patricksupportedhigh

In older adults, daily multivitamin supplementation with Centrum Silver in COSMOS randomized controlled trials reduced global cognitive aging by 2.1 years and episodic memory aging by 4.9 years.

"three very large randomized control trials, part of the COSMOS trials... older adults—so we're talking 65 years and older—that are taking a multivitamin supplement for, you know, what was it, a year?... And it was, by the way, Centrum Silver... it globally reduced brain aging by about 2.1 years from like three trials... And it also reduced episodic brain aging by 4.9 years." (said at 2:46:35)

The claim accurately reflects findings from the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized controlled trials and their meta-analysis evaluating daily multivitamin-mineral supplementation (Centrum Silver) in older adults. In the meta-analysis combining the three cognitive substudies (COSMOS-Mind, COSMOS-Web, and COSMOS-Clinic), daily multivitamin supplementation led to statistically significant improvements in global cognition and episodic memory, with effect estimates equivalent to slowing cognitive aging by approximately 2 years globally, while individual trial analyses (such as COSMOS-Mind and COSMOS-Web) reported slowing episodic memory aging by several years.

2:50:45Rhonda Patricksupportedhigh

Urolithin A is a metabolite produced by the gut microbiome from ellagitannin polyphenols found in foods like pomegranates, raspberries, and walnuts.

"urolithin A is something that is formed from a type of polyphenol that's found in some fruits, like pomegranate being the main one, I think. And raspberries may also have some. I think walnuts also, but it's ellagitannin is the polyphenol, and these ellagitannins get metabolized by the gut microbiome, and the metabolites that are formed, one of them is called urolithin A." (said at 2:50:45)

The speaker's statement is accurate. Urolithins, particularly urolithin A, are well-established microbially derived metabolites produced by the gut microbiota from dietary ellagitannins and ellagic acid, which are abundant in foods such as pomegranates, walnuts, raspberries, and strawberries.

2:51:16Rhonda Patricksupportedmoderate

Randomized controlled trials in humans demonstrate that urolithin A stimulates mitophagy in blood cells and skeletal muscle biopsy samples.

"urolithin A is a compound that seems to stimulate the process of mitophagy, which is a very specific form of autophagy that's that's only for mitochondria. And, you know, that's been shown in there have been randomized controlled trials showing this in humans. It does stimulate mitophagy in blood cells as well as muscle biopsy" (said at 2:51:16)

Randomized clinical trials evaluating oral urolithin A supplementation in healthy middle-aged and older adults demonstrated increases in mitochondrial biomarkers, plasma acylcarnitines, and expression of mitophagy- and mitochondrial-related genes and proteins in skeletal muscle biopsy samples and blood.

2:52:45Rhonda Patricksupportedhigh

When cruciferous vegetables containing glucoraphanin are crushed or chewed, an enzyme converts glucoraphanin into sulforaphane.

"glucoraphanin is in in these cruciferous vegetables like broccoli. Broccoli sprouts are really really great source of it. And when the plant is crushed, you know, like when you eat it eat broccoli or chew it, whatever, an enzyme is activated that converts glucoraphanin into sulforaphane." (said at 2:52:45)

The speaker's statement accurately describes established plant biochemistry. Cruciferous vegetables, particularly broccoli and broccoli sprouts (which contain substantially higher concentrations than mature plants), store the glucosinolate glucoraphanin. When plant tissue is crushed, chopped, or chewed, glucoraphanin is brought into contact with the enzyme myrosinase (a thioglucosidase), which hydrolyzes glucoraphanin into the bioactive isothiocyanate sulforaphane.

2:53:18Rhonda Patricksupportedhigh

Sulforaphane strongly activates the Nrf2 stress response pathway that upregulates detoxification genes.

"It's probably the the best naturally occurring dietary activator of a stress response pathway that is important for detoxification. And that that pathway is the Nrf2 pathway. I'm sure you've heard of that pathway. Sulforaphane is a very, very powerful activator of that pathway." (said at 2:53:18)

The speaker's claim is well supported by extensive biochemical and clinical literature. Sulforaphane, an isothiocyanate derived from cruciferous vegetables such as broccoli, is widely recognized as one of the most potent naturally occurring dietary activators of the Keap1-Nrf2-ARE signaling pathway, which upregulates phase II detoxification and antioxidant enzymes.

2:53:50Rhonda Patricksupportedhigh

Clinical studies in China demonstrated that broccoli sprout sulforaphane extract increased urinary excretion of airborne carcinogens like benzene by approximately 60% within 24 hours.

"the classic studies that have been done, some of them most of them in China where air pollution is very high, is that if you take, you know, this broccoli sprout sulforaphane extract, you can start to excrete compounds that are found in air pollution like benzene that are carcinogenic, right? And you can start to excrete it after 24 hours by like 60%" (said at 2:53:50)

Randomized controlled clinical trials conducted in Qidong, China, by Egner et al. (2014) and Chen et al. (2019) demonstrated that consumption of a broccoli sprout-derived beverage containing glucoraphanin and sulforaphane resulted in a rapid, statistically significant ~61% to 63% increase in the urinary excretion of benzene-derived mercapturic acid metabolites compared to placebo.

2:55:14Rhonda Patricksupportedlow

Human studies show that sulforaphane supplementation increases glutathione levels in both blood plasma and the brain via Nrf2 pathway activation.

"Also, it increases um it's been shown in human studies to very powerfully increase glutathione in both the plasma and the brain, and that's also through the Nrf2 pathway." (said at 2:55:14)

A clinical pilot study in healthy human volunteers (Sedlak et al., 2018, PMID 29888232) demonstrated that 7 days of oral sulforaphane supplementation increased blood glutathione (GSH) levels and brain GSH levels in multiple brain regions measured using 7-Tesla magnetic resonance spectroscopy (MRS). Mechanistically, sulforaphane is widely established to stimulate glutathione synthesis via activation of the Keap1/Nrf2 transcriptional pathway. However, the available direct human neuroimaging evidence is limited to small pilot studies.

2:55:29Rhonda Patricksupportedvery low

Sulforaphane deactivates phase I biotransformation enzymes that convert procarcinogens into active carcinogens, such as heterocyclic amines from charred meat.

"It also deactivates phase one biotransformation enzymes that are involved in um turning a procarcinogen into a carcinogen. So, those are things like you're eating, you know, you're you're grilling your meat at a high temperature and you're getting heterocyclic amines" (said at 2:55:29)

In vitro and preclinical cell-culture studies confirm that sulforaphane can inhibit or downregulate specific Phase I cytochrome P450 enzymes (such as CYP1A1 and CYP3A4) and protect against DNA adduct formation caused by dietary procarcinogens, including the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) formed in high-temperature meat cooking. Because the evidence for this specific mechanism is derived from in vitro and animal cell models, certainty is rated as very low.

2:57:57Rhonda Patricksupportedmoderate

Approximately 88% of the population in Switzerland meets physical activity recommendations.

"People in Switzerland being 80% Like 88% of them being physically active, they're way ahead of us on that." (said at 2:57:57)

Representative national survey data from Switzerland indicate that a large majority of the population meets physical activity recommendations. In the national menuCH survey evaluating adherence to cancer prevention and lifestyle recommendations in Switzerland, approximately 80% of adults met the physical activity recommendations. Depending on the survey cycle and definition used (e.g., Swiss Health Survey classifications of regularly active and sufficiently active individuals), self-reported adherence ranges from roughly 76% to nearly 88%.

2:59:12Andrew Huberman (host)supportedvery low

Numerous animal studies on peptide BPC-157 demonstrate accelerated cartilage repair, nerve regeneration, and angiogenesis.

"there are many, many animal studies on BPC-157 showing accelerated cartilage growth, nerve growth after injury, and on and on and on and on. And angio- angiogenesis." (said at 2:59:12)

The speaker accurately specifies that these findings originate from animal (preclinical) studies rather than clinical trials. Multiple systematic and narrative reviews confirm that extensive animal research on pentadecapeptide BPC-157 demonstrates promotion of angiogenesis (via pathways including VEGFR2 and eNOS activation), nerve regeneration and functional recovery after neural injury, and healing across musculoskeletal tissues including cartilage, tendon, ligament, and bone. Human clinical trials remain extremely sparse, so evidence certainty is very low.

3:03:36Rhonda Patricksupportedvery low

A study in mice with pancreatic cancer found that NMN administration accelerated the growth of the pancreatic cancer cells.

"There was a study on NMN in mice that they had The mice had tumors, and then they you know, gave them I think they injected them with NMN or maybe it was oral gavage. I don't remember which which way it was, but it accelerated the growth of those rare type of pancreatic cancer cells." (said at 3:03:36)

A 2019 study published in Nature Cell Biology by Nacarelli et al. (PMID: 30778219) investigated the effects of NAD+ metabolism and supplementation with nicotinamide mononucleotide (NMN) in mouse models. The researchers found that NMN supplementation enhanced the proinflammatory senescence-associated secretory phenotype (SASP) and promoted the proliferation/growth of pancreatic intraepithelial neoplasias and pancreatic neuroendocrine tumors in mice. Because this finding is based strictly on preclinical animal and cell culture experiments, the GRADE certainty is very low.

3:04:14Rhonda Patricksupportedhigh

A clinical study conducted in Australia showed that oral nicotinamide supplementation prevented non-melanoma skin cancer.

"he pointed me to some study out of Australia where I think it was maybe might have been nicotinamide that basically prevented some kind of it wasn't melanoma but it was another type of of skin cancer." (said at 3:04:14)

The speaker accurately describes the ONTRAC phase 3 randomized controlled trial conducted in Australia (Chen et al., NEJM 2015, PMID 26488693). In this study of 386 high-risk immunocompetent patients with a history of at least two non-melanoma skin cancers in the prior 5 years, oral nicotinamide (500 mg twice daily for 12 months) significantly reduced the rate of new non-melanoma skin cancers by 23% compared to placebo (P=0.02).

2:44:32Rhonda Patricksupportedmoderate

Chronic psychological stress and elevated cortisol levels lead to the depletion of magnesium in the body.

"When you're when you're stressed, when your cortisol goes up, you know, chronically, you're depleting magnesium." (said at 2:44:32)

Published clinical and physiological evidence supports the concept that stress and activation of the hypothalamic-pituitary-adrenal (HPA) axis promote magnesium loss. Stress-induced release of stress hormones (including cortisol and catecholamines) facilitates intracellular magnesium shifts and increases urinary magnesium excretion, potentially leading to magnesium depletion over time (often described in the literature as the 'stress-magnesium vicious circle').

2:50:18Rhonda Patricksupportedmoderate

Ubiquinol possesses higher bioavailability compared to ubiquinone, the oxidized form of coenzyme Q10.

"The ubiquinol is a little bit more bioavailable" (said at 2:50:18)

Comparative pharmacokinetic trials and mechanistic absorption studies demonstrate that ubiquinol (the reduced form of coenzyme Q10) generally has higher oral bioavailability than standard ubiquinone (the oxidized form), resulting in greater increases in plasma total CoQ10 concentrations. While formulation characteristics (such as lipid carrier matrix and solubilization) also significantly impact absorption, the claim that ubiquinol is modestly more bioavailable is accurate and well supported.

2:54:39Rhonda Patricksupportedvery low

Animal studies demonstrate that administration of sulforaphane protects against bisphenol A (BPA) toxicity.

"we do have animal evidence where, you know, animals are given a high dose of BPA and sulforaphane, and it protects against the toxicity." (said at 2:54:39)

The speaker specifically claimed that animal evidence exists showing sulforaphane protects against BPA toxicity. Published rodent studies confirm this: sulforaphane administration in mice exposed to bisphenol A (BPA) counteracts BPA-induced hepatic lipid accumulation, endoplasmic reticulum stress, and adipogenesis/weight gain. Because the supporting evidence is currently limited to preclinical animal and in vitro models, the GRADE certainty is very low.

3:07:07Andrew Huberman (host)supportedmoderate

Studies demonstrate that L-carnitine improves sperm and egg quality downstream of mitochondrial health.

"Have you experimented with, um, L-carnitine because of the mitochondrial effects? Cuz I was able to find some good studies on sperm and egg quality on my which are thought to be downstream of mitochondrial health." (said at 3:07:07)

Multiple published studies and systematic reviews support that L-carnitine can improve sperm and egg (oocyte) quality via mitochondrial mechanisms. Meta-analyses of randomized clinical trials show that carnitine supplementation improves sperm motility, progressive motility, and morphology in men with subfertility or idiopathic infertility. In female reproduction, reviews and experimental studies show that L-carnitine facilitates mitochondrial fatty acid β-oxidation (via carnitine palmitoyltransferase) and reduces oxidative stress, enhancing oocyte maturation and embryo quality (predominantly demonstrated in in vitro maturation and preclinical models).

3:07:38Rhonda Patricksupportedvery low

Research from Bruce Ames' lab showed that the combination of L-carnitine and alpha-lipoic acid improves mitochondrial health.

"yeah, carnitine a lot of those studies came out of my mentor's lab, Bruce Ames. So, he was he looked at the combination of L-carnitine and alpha-lipoic acid improving mitochondrial health. And came up with the supplement that it's it's called Juvenon now, but it's L-carnitine with alpha-lipoic acid." (said at 3:07:38)

Bruce Ames' laboratory published several landmark preclinical studies in 2002 (e.g., in PNAS) demonstrating that dietary supplementation with acetyl-L-carnitine (ALCAR) and (R)-alpha-lipoic acid (LA) reversed age-associated mitochondrial decay, reduced oxidative stress, improved mitochondrial enzyme activity (such as carnitine acetyltransferase), and enhanced cellular respiration and cognitive performance in aged rats. This work directly led to the commercial formulation of the supplement Juvenon. Because the underlying evidence is based on animal (rodent) models rather than human clinical trials, the GRADE certainty is rated very low.

3:08:39Andrew Huberman (host)supportedhigh

Oral L-carnitine has low absorption bioavailability and oral supplementation increases trimethylamine N-oxide (TMAO).

"You can get away with taking much lower milligram count. Otherwise, you have to take a lot of it because a lot of it just isn't absorbed if you take it orally. And then I was told that if you take it orally, you also have to do something to offset the increase in in TMAO." (said at 3:08:39)

Oral L-carnitine supplementation has low bioavailability (typically estimated between 5% and 18% for high oral supplement doses due to saturable active transport across the intestinal mucosa), meaning much higher oral doses are needed compared to parenteral delivery. Additionally, unabsorbed oral carnitine reaches the large intestine, where gut microbiota metabolize it into trimethylamine (TMA), which is oxidized by the liver into trimethylamine N-oxide (TMAO), leading to significant increases in plasma TMAO concentrations.

3:08:58Rhonda Patricksupportedhigh

Gut bacteria determine whether dietary L-carnitine and choline are converted into TMAO.

"It depends on your gut bacteria whether or not your metabolizing the L-carnitine into TMAO. There's actually a lot of complexity involved in that whole thing, but you can get your TMAO measured. So, if you're supplementing with it, I mean, the same goes for choline, you know, like if you're worried like choline can be converted into TMAO." (said at 3:08:58)

The speaker's statement is supported. Conversion of dietary L-carnitine and choline into trimethylamine N-oxide (TMAO) is an established metaorganismal pathway that strictly requires the intestinal microbiome. Specific gut bacteria express enzyme clusters (e.g., CutC/D for choline, CntA/B or the γ-butyrobetaine pathway for carnitine) to cleave these substrates into trimethylamine (TMA), which is then transported to the liver and oxidized to TMAO by host hepatic flavin-containing monooxygenases. Isotope-tracer clinical studies demonstrate that broad-spectrum antibiotics or the absence of specific carnitine-metabolizing taxa (as seen in long-term vegans/vegetarians) virtually abolishes or drastically diminishes TMAO generation following ingestion.

3:12:51Rhonda Patricksupportedmoderate

Taking exogenous ketones in a fasted state shuts down lipolysis.

"sometimes I'll take exogenous ketones, too. Although, if you take them in a fasted state, it kind of shuts down the lipolysis." (said at 3:12:51)

Exogenous administration of ketone bodies (such as beta-hydroxybutyrate) activates the hydroxycarboxylic acid receptor 2 (HCAR2/GPR109A) on adipocytes, mediating a negative feedback loop that acutely suppresses lipolysis and significantly reduces circulating free fatty acid (FFA) concentrations, even in states of stimulated lipolysis.

3:20:13Rhonda Patricksupportedmoderate

Studies in France and the US showed a larger volume and count of microplastics in glass bottled water compared to plastic bottled water due to paint on the metal lids.

"there was a study that came out showing that there's actually a larger volume of microplastics in within the study in from glass bottles versus plastic bottles, which was a very shocking finding. Um so there's more mice microplastic number coming from the the glass bottles. It turns out this was a study out of France. There was a study out of France and also in the US. It's the paint on the lids." (said at 3:20:13)

Studies evaluating microplastics and microparticles in bottled water have found surprisingly high counts in glass bottled water, often exceeding single-use plastic (PET) bottles. For instance, Schymanski et al. (2018) found microplastic concentrations ranging from 2,649 ± 2,857 particles/L in single-use PET bottles up to 6,292 ± 10,521 particles/L in glass bottles (and up to 195,047 ± 330,810 pigment particles/L). The polymers and pigments found in glass-bottled water did not match the bottle material itself but rather external sources such as cap coatings, lubricants, sealings, or label paints/pigments. A 2022 review (Danopoulos et al. / Pietrelli et al., PMID 35564678) similarly confirmed that reusable PET and glass bottles frequently exhibit higher microplastic contamination than single-use plastic containers due to cap abrasion, coatings, and bottle processing.

3:21:08Rhonda Patricksupportedmoderate

Larger microplastics are poorly absorbed through gut epithelial cells and are excreted in feces, whereas smaller particles are more readily absorbed.

"larger microplastics are not well absorbed through the gut epithelial cells. So when you're, you know, taking them in in the gut, they're coming out, they're being excreted through your your feces. And less likely to be taken up into your gut and then get into your body." (said at 3:21:08)

Evidence from in vitro cell models, animal studies, and toxicological reviews confirms that intestinal absorption and systemic translocation of ingested plastic particles are strongly size-dependent. Larger microplastics are poorly absorbed across the intestinal epithelial barrier and are predominantly eliminated via feces, whereas smaller microplastics and nanoplastics penetrate the mucosal barrier and translocate into systemic circulation more readily.

3:22:17Rhonda Patricksupportedlow

Reheating and repeatedly cooking polyunsaturated seed oils generates oxidized lipids that increase inflammatory markers.

"I was pretty convinced that if you are heating and reheating, you know, oils like they do in fast food, for sure, you're increasing inflammatory markers. That's been shown." (said at 3:22:17)

Preclinical and mechanistic evidence supports the claim that repeatedly heating cooking oils generates toxic lipid oxidation products (such as malondialdehyde and 4-hydroxy-2-nonenal) and promotes oxidative stress and elevated inflammatory markers (such as TNF-alpha). However, the direct causal evidence establishing marked elevations in systemic inflammatory markers from repeatedly heated oils is primarily derived from animal feeding models and in vitro studies rather than large-scale human randomized controlled trials.

3:22:28Rhonda Patricksupportedmoderate

Consuming higher amounts of polyunsaturated fatty acids and omega-6s increases vitamin E requirements due to lipid oxidation.

"And I think also when you're really having a higher level of, you know, omega-6s and stuff around, I'm not as concerned cuz I'm getting a lot of omega-3, but it does also increase your vitamin E requirements as well because of the oxidation of these polyunsaturated fatty acids." (said at 3:22:28)

Consuming higher amounts of dietary polyunsaturated fatty acids (PUFAs), including omega-6 fatty acids like linoleic acid, increases the physiological requirement for vitamin E. Vitamin E (primarily alpha-tocopherol) serves as the primary lipid-soluble antioxidant that protects unsaturated fatty acids and membrane lipids from peroxidative damage. Established nutritional guidelines and reviews generally define human requirements as approximately 0.4 to 0.6 mg of alpha-tocopherol per gram of dietary linoleic acid, with requirements scaling higher as intake and degree of fatty acid unsaturation increase.

3:23:08Rhonda Patricksupportedmoderate

Hot tub immersion provides the same deliberate heat exposure benefits as a sauna.

"I think now there's just there's evidence that the the benefits are really like the same. It's the deliberate heat exposure, right? You're getting that You're getting that through the hot tub or through the sauna." (said at 3:23:08)

Evidence supports the speaker's claim that hot water immersion (hot tub) and saunas provide comparable physiological benefits through passive heating. Both modalities increase core temperature, cardiac output, shear stress, and vascular endothelial function (such as flow-mediated dilation). Comparative physiological studies indicate that hot water immersion effectively raises core temperature and elicits equal or greater acute cardiovascular and thermoregulatory responses compared to traditional or infrared saunas due to the high thermal conductivity of water.

3:24:00Rhonda Patricksupportedmoderate

Bananas contain an enzyme (polyphenol oxidase) that degrades dietary polyphenols, such as flavan-3-ols or anthocyanins in blueberries, when blended together in smoothies.

"there's an enzyme that is produced in bananas that break down polyphenols, particularly ones that are found in blueberries. And the reason I was getting my smoothies was one for the greens, but two for the blueberries because the polyphenols have been shown to improve coordination. Love blueberries. So, um sorry sorry, don't mix the blueberry with the banana smoothie because it it has been shown to decrease the the polyphenols, which are important." (said at 3:24:00)

A controlled, single-blinded, cross-over randomized study in healthy volunteers (Ottaviani et al., 2023, PMID: 37615673) demonstrated that bananas contain high levels of the enzyme polyphenol oxidase (PPO). When flavan-3-ols were consumed in a banana-based smoothie (high PPO), peak plasma concentration of flavan-3-ol metabolites was reduced by 84% compared to controls, whereas a low-PPO mixed berry smoothie did not reduce bioavailability.

3:23:20Rhonda Patricksupportedhigh

Replacing dietary saturated fat with polyunsaturated seed oils improves blood lipid profiles.

"you can find all this data out there showing that, you know, if you replace, you know, saturated fat with some of these seed oils, there's improvements in lipid profiles." (said at 3:23:20)

Extensive randomized controlled trial evidence and meta-analyses consistently show that replacing dietary saturated fats (such as butter or animal fat) with polyunsaturated-rich plant and seed oils (such as safflower, sunflower, corn, soybean, and rapeseed oils) leads to significant improvements in blood lipid profiles, specifically by lowering total cholesterol and low-density lipoprotein cholesterol (LDL-C).

3:23:59Rhonda Patricksupportedlow

Blueberry polyphenols have been shown in scientific studies to improve motor coordination.

"the reason I was getting my smoothies was one for the greens, but two for the blueberries because the polyphenols have been shown to improve coordination." (said at 3:23:59)

Scientific studies, primarily in aging rodent models (evaluating rod walking, balance beam, and rotarod performance) and preliminary human trials (evaluating adaptive gait and balance in older adults), have demonstrated that blueberry polyphenols can improve motor coordination and functional mobility. However, the evidence base relies predominantly on animal studies, with human clinical trial data remaining preliminary.

7 No source found (not proven false)
0:40:08Rhonda Patrickunverifiedvery low

Consuming isolated saturated fat without a fiber matrix, such as plain butter, increases gut permeability.

"eating a very like ultra-processed food meal will do it. Interestingly enough, just eating a bunch of saturated fat without a fiber matrix, so like butter. You're just like eating butter. Don't ever do that, but like if you just eat butter that's been shown." (said at 0:40:08)

No published clinical or mechanistic records directly evaluating the specific claim that isolated butter ingestion without a fiber matrix increases intestinal permeability were retrieved within the search budget. While dietary saturated fats and high-fat challenge meals have been investigated in relation to postprandial endotoxemia and intestinal barrier dynamics in animal models and small human trials, direct confirmation of the specific assertion regarding isolated butter versus a fiber matrix could not be verified.

1:18:30Rhonda Patrickunverifiedvery low

In a study of healthy young men, consuming an extra 1,200 to 1,500 calories per day of high-saturated-fat and high-sugar foods for five days induced brain insulin resistance and visceral/liver fat accumulation without overall weight gain.

"There was a study that was published actually quite recently... it was healthy young men, and researchers put them on a little bit of a calorically dense, so it was like they were eating 1,200 to 1,500 more calories a day, and it was high saturated fat, high sugar... for 5 days... their they did cause their brains to become insulin resistant, and they didn't gain weight, but they gained visceral fat. And they started gaining fat around their liver." (said at 1:18:30)

No published study matching the specific protocol described—healthy young men consuming an extra 1,200 to 1,500 kcal/day of high-saturated-fat and high-sugar foods for five days resulting in brain insulin resistance and visceral/hepatic fat accumulation in the absence of overall weight gain—was located in PubMed or Europe PMC. While short-term hypercaloric feeding trials have examined peripheral insulin sensitivity and liver fat accumulation, this specific study assessing brain insulin resistance under these exact parameters could not be verified against published literature.

1:52:40Rhonda Patrickunverifiedlow

Approximately 40% of people do not show significant cardiorespiratory fitness improvement from standard moderate-intensity cardiovascular exercise alone (non-responders).

"cardiorespiratory fitness is improved by aerobic exercise in general. That's great. And then, you know, if you if you add in high-intensity interval training in there, mix that also really helps because there are some people that don't respond necessarily to just doing cardiovascular Yeah, about 40% of people don't respond." (said at 1:52:40)

No publication verifying the exact claim that approximately 40% of individuals are non-responders to standard moderate-intensity cardiovascular exercise alone was fetched within the search limits. In exercise physiology literature (such as the HERITAGE Family Study and subsequent individual response trials), non-response rates for VO2max improvement vary widely depending on the statistical threshold, measurement error, training duration, and exercise volume/intensity (often ranging from ~10% to over 30% under fixed-dose protocols, with higher-intensity interval training or increased volume frequently eliciting adaptations in apparent non-responders). However, without retrieving a specific peer-reviewed record corroborating the 40% figure, the specific claim remains unverified.

2:08:17Rhonda Patrickunverifiedvery low

The human body (including the liver and brain) synthesizes between 1 and 3 grams of creatine per day.

"We make to some degree, you know, between 1 to 3 g of creatine a day. Our liver, our brain also makes it." (said at 2:08:17)

No directly matching publication could be retrieved within the search budget to verify the specific quantitative range of 1 to 3 grams per day of endogenous creatine synthesis across the liver and brain. While established biochemical literature recognizes that the human body endogenously synthesizes creatine primarily via the kidneys and liver (with local synthesis occurring in the brain) at approximately 1 to 2 g/day to replace non-enzymatic creatinine degradation, this specific claim could not be verified from the fetched database records.

3:09:21Andrew Huberman (host)unverifiedvery low

Alpha-GPC improves REM sleep duration.

"Alpha-GPC [clears throat] actually will improve your REM sleep. It's not a huge effect, but you'll notice you'll get more REM sleep." (said at 3:09:21)

No published clinical trials or human sleep studies demonstrate that Alpha-GPC (choline alphoscerate) supplementation increases REM sleep duration. While cholinergic neurotransmission is known to regulate REM sleep, direct testing of glycerophosphorylcholine (GPC) in an animal model failed to increase paradoxical (REM) sleep time, and available human reviews only note theoretical interest in sleep architecture without clinical trial confirmation.

3:10:42Andrew Huberman (host)unverifiedvery low

Withdrawal from nicotine causes smooth muscle throat spasms and a clearing tick due to muscarinic receptor activation.

"I think the the big issue is that if I take it, I start getting the spasm in my throat when I don't take it. And that's cuz of it's I have a friend who works on these pathways and it's because of the activation of the muscarinic receptors. So So on smooth muscle, you start getting a tick and kind of clearing [clears throat] of your throat and then you take more nicotine, you feel fine." (said at 3:10:42)

No published clinical or pharmacological literature supports the claim that nicotine withdrawal causes throat spasms or a throat-clearing tic via muscarinic receptor activation on smooth muscle. Furthermore, the proposed mechanism contains several basic pharmacological and anatomical inaccuracies: nicotine acts directly on nicotinic acetylcholine receptors (nAChRs) rather than muscarinic acetylcholine receptors (mAChRs), and the pharyngeal and laryngeal muscles responsible for throat spasms and throat clearing are striated (skeletal) muscle, not smooth muscle.

3:11:56Andrew Huberman (host)unverifiedvery low

A brain imaging study out of Washington University compared ADHD medications to sleep and found no direct focus enhancement from Ritalin, finding it only increases alertness equivalent to a good night's sleep.

"there's a study for out of WashU recently, really really talented researcher. I want to bring him on this podcast. Does brain imaging and he compared um essentially the effects of drugs for ADHD versus a good night's sleep. And basically found that there's no focus enhancement of Adderall, Vyvanse, Ritalin type drugs. They mainly looked at Ritalin. All it's doing is increasing alertness to the level that you would get after after a good night's sleep." (said at 3:11:56)

No published neuroimaging or clinical study from Washington University (or elsewhere) matching the description—directly comparing the cognitive and neural effects of ADHD stimulant medications (such as methylphenidate/Ritalin) to a full night's sleep and concluding that stimulants provide no focus enhancement beyond restoring baseline alertness—could be identified in biomedical databases. This does not prove such research does not exist (it may refer to unpublished work, preprints, or a misattributed finding), but the specific claim remains unverified in the peer-reviewed literature.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.